<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:05:14Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5473940" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5473940</identifier><datestamp>2017-06-26</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cell</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cell</journal-id>
      <journal-title-group>
        <journal-title>Cell</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0092-8674</issn>
      <issn pub-type="epub">1097-4172</issn>
      <publisher>
        <publisher-name>Cell Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5473940</article-id>
      <article-id pub-id-type="pmcid">PMC5473940</article-id>
      <article-id pub-id-type="pmc-uid">5473940</article-id>
      <article-id pub-id-type="pmid">28622508</article-id>
      <article-id pub-id-type="publisher-id">S0092-8674(17)30590-1</article-id>
      <article-id pub-id-type="doi">10.1016/j.cell.2017.05.029</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>SAF-A Regulates Interphase Chromosome Structure through Oligomerization with Chromatin-Associated RNAs</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nozawa</surname>
            <given-names>Ryu-Suke</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Boteva</surname>
            <given-names>Lora</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Soares</surname>
            <given-names>Dinesh C.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Naughton</surname>
            <given-names>Catherine</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dun</surname>
            <given-names>Alison R.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Buckle</surname>
            <given-names>Adam</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramsahoye</surname>
            <given-names>Bernard</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bruton</surname>
            <given-names>Peter C.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saleeb</surname>
            <given-names>Rebecca S.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arnedo</surname>
            <given-names>Maria</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hill</surname>
            <given-names>Bill</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Duncan</surname>
            <given-names>Rory R.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maciver</surname>
            <given-names>Sutherland K.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gilbert</surname>
            <given-names>Nick</given-names>
          </name>
          <email>nick.gilbert@ed.ac.uk</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">5</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UK</aff>
      <aff id="aff2"><label>2</label>Centre for Genomics and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UK</aff>
      <aff id="aff3"><label>3</label>Centre for Integrative Physiology, Edinburgh Medical School, University of Edinburgh, George Square, Edinburgh EH8 9XD, UK</aff>
      <aff id="aff4"><label>4</label>Edinburgh Super-Resolution Imaging Consortium, Institute of Biological Chemistry, Biophysics, and Bioengineering, Heriot-Watt University, Edinburgh EH14 4AS, UK</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author <email>nick.gilbert@ed.ac.uk</email></corresp>
        <fn id="fn1">
          <label>5</label>
          <p id="ntpara0010">Lead Contact</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>15</day>
        <month>6</month>
        <year>2017</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <day>15</day>
        <month>6</month>
        <year>2017</year>
      </pub-date>
      <volume>169</volume>
      <issue>7</issue>
      <fpage>1214</fpage>
      <lpage>1227.e18</lpage>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>10</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>13</day>
          <month>3</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>5</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2017 The Authors</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
        </license>
      </permissions>
      <abstract id="abs0010">
        <title>Summary</title>
        <p>Higher eukaryotic chromosomes are organized into topologically constrained functional domains; however, the molecular mechanisms required to sustain these complex interphase chromatin structures are unknown. A stable matrix underpinning nuclear organization was hypothesized, but the idea was abandoned as more dynamic models of chromatin behavior became prevalent. Here, we report that scaffold attachment factor A (SAF-A), originally identified as a structural nuclear protein, interacts with chromatin-associated RNAs (caRNAs) via its RGG domain to regulate human interphase chromatin structures in a transcription-dependent manner. Mechanistically, this is dependent on SAF-Aâs AAA<sup>+</sup> ATPase domain, which mediates cycles of protein oligomerization with caRNAs, in response to ATP binding and hydrolysis. SAF-A oligomerization decompacts large-scale chromatin structure while SAF-A loss or monomerization promotes aberrant chromosome folding and accumulation of genome damage. Our results show that SAF-A and caRNAs form a dynamic, transcriptionally responsive chromatin mesh that organizes large-scale chromosome structures and protects the genome from instability.</p>
      </abstract>
      <abstract abstract-type="graphical" id="abs0015">
        <title>Graphical Abstract</title>
        <fig id="undfig1" position="anchor">
          <graphic xlink:href="fx1"/>
        </fig>
      </abstract>
      <abstract abstract-type="author-highlights" id="abs0020">
        <title>Highlights</title>
        <p>
          <list list-type="simple">
            <list-item id="u0010">
              <label>â¢</label>
              <p>SAF-A remodels interphase chromosome structure</p>
            </list-item>
            <list-item id="u0015">
              <label>â¢</label>
              <p>Transcription regulates SAF-A oligomerization with caRNAs</p>
            </list-item>
            <list-item id="u0020">
              <label>â¢</label>
              <p>SAF-A and caRNAs interact to form a chromatin mesh</p>
            </list-item>
            <list-item id="u0025">
              <label>â¢</label>
              <p>Chromatin structure affects genome stability</p>
            </list-item>
          </list>
        </p>
      </abstract>
      <abstract abstract-type="teaser" id="abs0025">
        <p>A scaffolding protein interacts with chromatin-associated RNAs to regulate human interphase chromatin structures in a transcription-dependent manner.</p>
      </abstract>
      <kwd-group id="kwrds0010">
        <title>Keywords</title>
        <kwd>chromatin</kwd>
        <kwd>transcription</kwd>
        <kwd>nuclear architecture</kwd>
        <kwd>chromatin compaction</kwd>
        <kwd>chromatin-associated RNAs</kwd>
        <kwd>hnRNPU</kwd>
        <kwd>SAF-A</kwd>
        <kwd>AAA<sup>+</sup> ATPases</kwd>
        <kwd>chromosome stability</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <p id="misc0010">Published: June 15, 2017</p>
    </notes>
  </front>
  <body>
    <sec id="sec1">
      <title>Introduction</title>
      <p>Mammalian interphase chromosomes are organized into topologically constrained chromatin domains (<xref rid="bib4" ref-type="bibr">Belmont etÂ al., 1989</xref>), which are responsive to transcription (<xref rid="bib44" ref-type="bibr">Naughton etÂ al., 2013</xref>) and local gene density (<xref rid="bib23" ref-type="bibr">Goetze etÂ al., 2007</xref>). Gene-poor genomic regions have a compact large-scale chromatin structure, while regions rich in genes and transcriptional activity have a more decompacted structure (<xref rid="bib22" ref-type="bibr">Gilbert etÂ al., 2004</xref>, <xref rid="bib23" ref-type="bibr">Goetze etÂ al., 2007</xref>, <xref rid="bib43" ref-type="bibr">Naughton etÂ al., 2010</xref>). Previously, we suggested that transcription and topoisomerase activities, that occur at the gene level, alter local topology to form supercoiling domains (<xref rid="bib44" ref-type="bibr">Naughton etÂ al., 2013</xref>) and these correspond to structures seen by Hi-C (<xref rid="bib49" ref-type="bibr">Rao etÂ al., 2014</xref>). It is unclear, however, how these processes could impact on large-scale chromatin structures.</p>
      <p>In contrast to mitosis, where topoisomerases and condensin play a central role in scaffolding chromatin (<xref rid="bib52" ref-type="bibr">Samejima etÂ al., 2012</xref>), the molecular underpinnings of interphase domains are poorly characterized (<xref rid="bib3" ref-type="bibr">Belmont, 2014</xref>) and their functional impact remains unknown. A ânuclear matrixâ consisting of insoluble proteins and RNA particles was proposed to organize interphase chromatin architecture (<xref rid="bib5" ref-type="bibr">Berezney and Coffey, 1974</xref>, <xref rid="bib46" ref-type="bibr">Pederson, 1998</xref>), maintain chromosome territories (<xref rid="bib39" ref-type="bibr">Ma etÂ al., 1999</xref>), enhance gene expression, and provide a platform for nuclear processes, but chromatin mobility inÂ vivo (<xref rid="bib10" ref-type="bibr">Chubb etÂ al., 2002</xref>, <xref rid="bib47" ref-type="bibr">Phair etÂ al., 2004</xref>) and the lack of a stable nucleoprotein structure in live cells undermined the concept (<xref rid="bib29" ref-type="bibr">Hancock, 2000</xref>). However, the structural contribution of RNA to chromatin organization remains undisputed: a large proportion of chromatin by mass corresponds to RNA (<xref rid="bib31" ref-type="bibr">Holmes etÂ al., 1972</xref>), mostly belonging to the loosely termed chromatin-associated RNA (caRNA) class. The functional roles of caRNAs are hinted by the observation that they are stably associated with interphase chromosome territories (<xref rid="bib20" ref-type="bibr">Fey etÂ al., 1986</xref>, <xref rid="bib27" ref-type="bibr">Hall and Lawrence, 2016</xref>) and their disruption leads to chromatin condensation (<xref rid="bib28" ref-type="bibr">Hall etÂ al., 2014</xref>). The molecular basis for this is unknown, but it is thought heterogeneous ribonucleoprotein particles (hnRNPs) provide a docking platform to associate with nascent transcripts (<xref rid="bib41" ref-type="bibr">MelÃ© and Rinn, 2016</xref>) while caRNAs might influence chromatin structure (<xref rid="bib9" ref-type="bibr">Caudron-Herger and Rippe, 2012</xref>). Recent studies have been unable to find specific species of RNA, similar to XIST, which could regulate large-scale chromatin structure, suggesting instead that diverse caRNAs transiently interact with chromatin, forming a dynamic compartment (<xref rid="bib41" ref-type="bibr">MelÃ© and Rinn, 2016</xref>). However, a refinement of this model would require insight into how the interaction of proteins with caRNAs can regulate chromatin structure.</p>
      <p>Scaffold attachment factor A (SAF-A), also known as heterogeneous ribonucleoprotein U (HNRNP-U) (<xref rid="bib35" ref-type="bibr">Kiledjian and Dreyfuss, 1992</xref>, <xref rid="bib50" ref-type="bibr">Romig etÂ al., 1992</xref>), is an abundant protein reported to bind scaffold attachment regions (<xref rid="bib24" ref-type="bibr">GÃ¶hring etÂ al., 1997</xref>) and involved in several cellular processes such as pre-mRNA splicing (<xref rid="bib59" ref-type="bibr">Xiao etÂ al., 2012</xref>), accumulation at DNA damage sites (<xref rid="bib8" ref-type="bibr">Britton etÂ al., 2014</xref>) and Xist-mediated transcriptional silencing (<xref rid="bib40" ref-type="bibr">McHugh etÂ al., 2015</xref>). Structurally, SAF-A contains a low complexity RNA-binding RGG repeat and an ATP-binding AAA<sup>+</sup> domain, known to facilitate the assembly (<xref rid="bib17" ref-type="bibr">Erzberger and Berger, 2006</xref>) and operation of diverse protein and nucleoprotein machines. Other well-characterized AAA<sup>+</sup> domain-containing proteins, such as replication factor C (RFC) and DnaA, oligomerize through their AAA domains, often with nucleic acids, to form higher molecular weight structures. We characterized SAF-A activity to understand the relationship between its structure and function in regulating chromatin architecture.</p>
      <p>We are able to demonstrate that SAF-A regulates transcriptionally active large-scale chromatin structures in human cells. Using functional mutants of SAF-A, we dissect the underlying molecular mechanisms to show that SAF-A can cycle from a monomeric to a homo-oligomeric state through ATP binding and caRNAs; concomitantly, SAF-A oligomerization drives chromatin decompaction while monomerization compacts large-scale chromatin organization.</p>
      <p>We suggest that SAF-A interacts with caRNAs to form a chromatin mesh (<xref rid="bib45" ref-type="bibr">Nozawa and Gilbert, 2014</xref>), and unlike the historical concept of a nuclear matrix, is highly responsive to ongoing transcription and can undergo dynamic cycles of assembly and disassembly. Surprisingly, a gross change in chromatin structure has limited effect on transcription indicating that gene-level chromatin structure is important for regulating transcription, rather than large-scale chromatin architecture. Although changes in large-scale chromatin structure do not influence gene expression, an alteration in the chromatin landscape had a dramatic effect on genome stability; loss or mutation of SAF-A triggered a DNA damage response and chromosomal instability.</p>
      <p>To unify the structural and enzymatic aspects of SAF-A function, we speculate that SAF-A/RNA interactions will drive the formation of local chromatin domains or micro-bodies (<xref rid="bib7" ref-type="bibr">Brackley etÂ al., 2016</xref>), while its role in regulating large-scale chromatin structures will partition the genome into functionally diverse segments. This process is essential for maintaining genome stability and could provide a constraint to maintain clusters of genes together in the genome during evolution (<xref rid="bib21" ref-type="bibr">Ghanbarian and Hurst, 2015</xref>).</p>
    </sec>
    <sec id="sec2">
      <title>Results</title>
      <sec id="sec2.1">
        <title>SAF-A Remodels Chromatin Structures</title>
        <p>SAF-Aâs contribution to chromatin structure is unknown; it is nuclear diffuse (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>A), but excluded from condensed DAPI bright regions such as the gene-poor nuclear periphery. SAF-Aâs abundance, localization, and structural characteristics suggest it may play a role in organizing nuclear architecture (<xref rid="bib27" ref-type="bibr">Hall and Lawrence, 2016</xref>). To examine whether SAF-A affects large-scale chromatin, we analyzed chromatin compaction using three-dimensional (3D) DNA fluorescence inÂ situ hybridization (FISH) across loci with different epigenetic states and distinct levels of chromatin folding (<xref rid="bib6" ref-type="bibr">Boettiger etÂ al., 2016</xref>, <xref rid="bib22" ref-type="bibr">Gilbert etÂ al., 2004</xref>) using fosmid probe pairs (<xref rid="fig1" ref-type="fig">Figures 1</xref>A and <xref rid="figs1" ref-type="fig">S1</xref>C; <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>) (detailed in <xref rid="bib44" ref-type="bibr">Naughton etÂ al., 2013</xref>). SAF-A small interfering RNA (siRNA) treatment resulted in a substantial reduction of SAF-A protein (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>B) and caused a significant compaction of gene-rich 11p15.5 and 11p15.1 loci enriched in âopenâ chromatin, but not the gene-poor 11p14.1 locus (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>B), indicating that SAF-A is involved in decompacting chromatin. Similar changes in chromatin structure were observed for additional gene-rich (2p25.1, 21q22.3, Xq13.1) and gene-poor loci (Xq25, 1p31.2) using fosmid probes positioned 0.1â2.0 Mb apart (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>D). Depletion of other hnRNP members, such as HNRNP A1 and HNRNP C, showed no obvious nuclear effects (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>C), indicating that SAF-A has a unique role among hnRNPs in regulating chromatin structure. To extend our analysis, we targeted labeled oligo probes to gene-rich and gene-poor regions on chromosome 11 (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>A) and analyzed chromatin compaction by FISH and 3D modeling. SAF-A depletion led to significant compaction of the HSA11 gene-rich domain, but not the gene-poor region (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>D), indicating that SAF-A contributes to the partitioning of the genome into segments with distinct structures (<xref rid="bib6" ref-type="bibr">Boettiger etÂ al., 2016</xref>). Changes in chromatin compaction following SAF-A depletion were observed by 24Â hr, while global changes in nuclear area were not apparent until later, indicating that the effect is due to changes in local chromatin structure rather than an alteration in nuclear size (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>F).<fig id="fig1"><label>FigureÂ 1</label><caption><p>Transcription-Dependent SAF-A Regulation of Interphase Chromosome Structures</p><p>(A) Ideogram of human chromosome 11 (HSA11) showing locations of fosmid probes at p15.5, p15.1, and p14.1 and oligo probe clusters located in gene-rich (green) and gene-poor (red) regions.</p><p>(B) FISH assay for large scale chromatin compaction with probes (red and green) at gene-rich 11p15.5, 11p15.1, or gene-poor 11p14.1 loci in human RPE1 cells. Left: Representative images for cells (siControl) or cells depleted of SAF-A (siSAF-A); nuclei were counterstained with 4â²,6-diamidino-2-phenylindole (DAPI; blue). Scale bars, 10Â Î¼m. Right: Boxplots showing distribution of distances between probe pairs. Shaded boxes show median and interquartile range of data (nÂ = 70 nuclei for at least two biological replicates).</p><p>(C) Boxplots of distances between probe pairs at 11p15.5 from a FISH assay in cells (siControl) or cells depleted of hnRNP A1 or hnRNP C.</p><p>(D) Left: FISH with fluorescently labeled oligo probes covering gene-rich (see A; green) or gene-poor region (see A; red) in cells (siControl) or cells depleted of SAF-A (siSAF-A). Scale bars, 10Â Î¼m. Inset: 3D reconstructions of probe clusters to facilitate visualization. Scale bars, 1Â Î¼m. Right: Quantification of volumes occupied by probe clusters (n &gt; 20 nuclei for each sample).</p><p>(E) Left: FISH for chromosome 18 (HSA18) and 19 (HSA19) territories in cells (siControl) or cells depleted of SAF-A (siSAF-A). Scale bars, 10Â Î¼m. Right: quantification of territory area (n &gt; 50 nuclei for each sample).</p><p>(F) Boxplots showing the distribution of distances between probe pairs at 11p15.5 from a FISH assay in cells (siControl) or cells depleted of SAF-A (siSAF-A) in the presence and absence of the transcription inhibitor Î±-amanitin (5Â hr). All conditions are significantly different from the untreated control (pÂ &lt; 0.0001, nÂ = 100 nuclei for at least two biological replicates).</p><p>p values for a Wilcoxon test: NS, not significant; <sup>âââ</sup>pÂ &lt; 0.001; <sup>ââââ</sup>pÂ &lt; 0.0001.</p><p>See also <xref rid="figs1" ref-type="fig">FigureÂ S1</xref> and <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>.</p></caption><graphic xlink:href="gr1"/></fig><fig id="figs1"><label>FigureÂ S1</label><caption><p>Characterization of SAF-Aâs Ability to Regulate Interphase Chromosome Structures, Related to <xref rid="fig1" ref-type="fig">FigureÂ 1</xref></p><p>(A) Immunofluorescence staining showing the distribution of SAF-A (red) and DAPI-stained DNA (blue) in ARPE-19 cells. Scale bars, 10Â Î¼m.</p><p>(B) western blot for SAF-A and GAPDH in RPE1 cells (siControl) and cells depleted of SAF-A (siSAF-A).</p><p>(C) Ideogram of human chromosome 1 (HSA1), 2 (HSA2), 18 (HSA18), 19 (HSA19), 21 (HSA21) and X (HSA X) showing fosmid probe pairs used in this study at 1p31.2, 2p25.1, 21q22.3, Xq13.1 and Xq25. Whole chromosome paints were used for HSA 18 and HSA 19.</p><p>(D) Top, representative images of FISH experiments showing control cells (siControl) or cells depleted of SAF-A (siSAF-A). Scale bars, 10Â Î¼m. Bottom, boxplots of inter-probe distances at gene rich Xq13.1, 2p25.1 and 21q22.3 regions and gene poor Xq25 and 1p31.2 from a FISH chromatin compaction assay in RPE1 cells. P values for a Wilcoxon test (n &gt; 50; NSÂ = not significant; <sup>ââ</sup>pÂ &lt; 0.01; <sup>âââ</sup>pÂ &lt; 0.001).</p><p>(E) western blot for hnRNPA1 (left panel) or hnRNPC (right panel) and histone H3 in RPE1 control cells (siControl) and cells depleted of hnRNP A1 (left) or hnRNP C (right).</p><p>(F) Left, boxplots of distances between probe pairs at 11p15.5 from a FISH assay in control cells (siControl) or cells depleted of SAF-A (siSAF-A) for increasing amount of time (24, 48, 72 h). Right, boxplots of nuclear area in control cells (0 h) or cells depleted of SAF-A (siSAF-A) for increasing times (24, 48, 72 h).</p><p>(G) Confocal images of DAPI-stained nuclei in control RPE1 cells (siControl) and RPE1 cells depleted of SAF-A (siSAF-A). Scale bar, 5Â Î¼m.</p><p>(H) Diagram showing how nuclei are sampled to measure DNA texture.</p><p>(I) Boxplots for different sample window sixes (x axis) for different texture properties (y axis) in control (red) and SAF-A depleted (green) cells. Contrast â local intensity variation; Correlation â gray level linear dependence; Energy â homogeneity (a homogeneous scene will have only a few gray levels); Entropy â homogeneity (Homogeneous scenes have a high entropy).</p></caption><graphic xlink:href="figs1"/></fig></p>
        <p>The human genome is partitioned into chromosomes with very different gene densities; we reasoned that if SAF-A predominantly regulated gene-rich chromosome regions, its depletion would have a greater effect on gene-rich, rather than gene-poor chromosomes. To test this, we monitored the chromosome territory of the gene-rich HSA19 and gene-poor HSA18 before and after SAF-A depletion. The two similarly sized chromosomes have different gene densities (45 genes/Mb on HSA18 versus 216 genes/Mb on HSA19) (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>C), and HSA19 has been shown to adopt a more open chromosome territory configuration than HSA18 (<xref rid="bib11" ref-type="bibr">Croft etÂ al., 1999</xref>). Upon SAF-A depletion, we observed significant chromosome territory compaction, but HSA19 was compacted significantly more that HSA18, consistent with SAF-A predominantly regulating gene-rich chromosome regions at scales up from 100 kb to a whole chromosome territory (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>E). At the largest nuclear scale, we also observed a significant change in DAPI texture (<xref rid="figs1" ref-type="fig">Figures S1</xref>G and S1H) after SAF-A depletion.</p>
        <p>Previously, we reported that transcription also decompacts large scale chromosome structures (<xref rid="bib43" ref-type="bibr">Naughton etÂ al., 2010</xref>). To determine whether SAF-A and transcription act independently or in a synergistic manner, we analyzed chromatin compaction in control cells or cells depleted of SAF-A following treatment with the transcription inhibitor Î±-amanitin. Inhibition of transcription and loss of SAF-A together did not result in a further compaction of chromatin than either of the two factors alone, consistent with the two processes functioning together (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>F).</p>
      </sec>
      <sec id="sec2.2">
        <title>Transcriptional Upstream Regulation of SAF-A</title>
        <p>We reasoned that if SAF-A and transcription acted together, there could be two potential models for the functional relationship between SAF-A, transcription, and chromatin: either transcription could regulate SAF-A to alter chromatin structure (model 1) or SAF-A could have an impact on transcription, which regulates structure (model 2) (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>A). To discriminate between these possibilities, we investigated the effect of SAF-A depletion on cellular transcription using different approaches. First, we examined global transcription via a short pulse of 5-ethynyl uridine (5-EU) incorporated into newly transcribed RNA (â¼80% pol II transcripts) (<xref rid="bib33" ref-type="bibr">Jackson etÂ al., 2000</xref>) and quantified by fluorescent labeling (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>B). Depletion of SAF-A had little effect on the distribution of transcripts or the apparent levels of transcription. In contrast, inhibition of transcription using Î±-amanitin had a profound effect on newly synthesized RNA. To confirm these results, [5-<sup>3</sup>H]uridine was pulsed into cells and measured in newly synthesized RNA; there was no change in transcription after 24 or 48Â hr of SAF-A depletion (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>A). This analysis was extended by pulsing cells with 4-thiouridine before analyzing the nucleoside composition of RNA and DNA (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>B). SAF-A depletion had little effect on either nascent RNA or steady-state RNA levels (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>C). Consistently, cytological markers of transcription (Ki67 and SC35) showed no changes in their distribution after SAF-A depletion (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>C). To determine if individual transcripts were affected, we analyzed mRNA by next generation sequencing. At 24Â hr following depletion, only SAF-A was differentially expressed compared to control cells, while at 48Â hr, there were limited changes in cell-cycle-dependent genes (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>D) consistent with other studies (<xref rid="bib59" ref-type="bibr">Xiao etÂ al., 2012</xref>, <xref rid="bib60" ref-type="bibr">Ye etÂ al., 2015</xref>). These results were validated by qRT-PCR (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>D) providing overwhelming evidence that transcription is upstream of SAF-A (model 1). To further support model 1, we reasoned that changes in transcription might be expected to influence SAF-A behavior. In control cells SAF-A is insoluble (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>E), but after transcription, inhibition SAF-A is released into a soluble fraction consistent with transcription being functionally upstream of SAF-A (model 1). These surprising results indicate that while SAF-A exerts a significant effect on large-scale chromatin structures (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>), there is a limited concomitant effect on transcription, suggesting it is small-scale chromatin structures that predominantly impact transcriptional processes.<fig id="fig2"><label>FigureÂ 2</label><caption><p>SAF-A Modulation of Chromatin Structure Is Downstream and Regulated by Gene Transcription</p><p>(A) Alternate models depicting the relationship between transcription, SAF-A, and chromatin structure.</p><p>(B) Fluorescence microscopy of cells pulse labeled (30Â min) with 5-EU, fixed and conjugated, using click chemistry with Cy5 azide. Control cells (siControl), cells depleted of SAF-A (siSAF-A), or treated with Î±-amanitin (5 h). Scale bar, 10Â Î¼m.</p><p>(C) Bar graph showing nascent and steady-state RNA in control RPE1 cells or cells depleted of SAF-A quantified by measuring the pulsed incorporation of 4-SU, guanine, and thymidine. Error bars represent SD for two biological replicates.</p><p>(D) Relative expression of HPS5, LDHA, and TSG101 in control cells and cells depleted of SAF-A measured by qRT-PCR. Error bars are SEM for at least two biological replicates.</p><p>(E) Left: Western blot showing fractionation of SAF-A protein into soluble and insoluble fractions in control cells or cells treated (5Â hr) with Î±-amanitin or flavopiridol. Right: Immunofluorescence for SAF-A in Triton X-100 extracted cells treated with Î±-amanitin and counterstained with DAPI. Scale bars, 10Â Î¼m.</p><p>See also <xref rid="figs2" ref-type="fig">FigureÂ S2</xref>.</p></caption><graphic xlink:href="gr2"/></fig><fig id="figs2"><label>FigureÂ S2</label><caption><p>SAF-A Loss Does Not Impact on Gene Transcription, Related to <xref rid="fig2" ref-type="fig">FigureÂ 2</xref></p><p>(A) Bar graph showing [5-3H]uridine incorporation into nascent RNA in control RPE1 cells or cells depleted of SAF-A. Error bars are SEM for at least two biological replicates.</p><p>(B) HPLC traces showing the identification and quantification of 4-SU nucleoside monophosphate (top, red circle), guanine monophosphate and thymidine mono phosphate peaks (bottom, red boxes) after isolating and fractionating nucleosides from whole cell extracts pulsed with 4-SU in the presence or absence of competitor ribonucleosides.</p><p>(C) Immunofluorescence staining for Ki67 (red) or SC35 (green) in RPE1 control cells (siControl), cells depleted for SAF-A (siSAF-A) or treated with transcription inhibitor Î±-amanitin, flavopiridol, actinomycin D or DRB (each for 5 h). Scale bar, 10Â Î¼m.</p><p>(D) Volcano plots for RNA-seq data for RPE1 control cells compared to cells depleted of SAF-A for 24 or 48Â hr. Significantly differently expressed genes (qÂ &lt; 0.05) are shown in red.</p></caption><graphic xlink:href="figs2"/></fig></p>
      </sec>
      <sec id="sec2.3">
        <title>SAF-A Actuation by ATP Binding</title>
        <p>To understand the relationship between SAF-A and transcription and how SAF-A mechanistically impacts chromatin, we undertook a structural analysis of the SAF-A protein. SAF-A encodes four conserved domains (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>A): SAP (SAF-A/B, acinus, and PIAS) that has DNA binding activity (<xref rid="bib24" ref-type="bibr">GÃ¶hring etÂ al., 1997</xref>), SPRY (SPla and the ryanodine receptor) of unknown function, AAA<sup>+</sup> (ATPases associated with diverse cellular activities) (<xref rid="bib17" ref-type="bibr">Erzberger and Berger, 2006</xref>), and a low complexity RGG (arginine glycine-glycine) RNA-binding domain (<xref rid="bib30" ref-type="bibr">Helbig and Fackelmayer, 2003</xref>). Globular domain composition and disorder prediction indicate that the SPRY and AAA<sup>+</sup> domain are ordered but separated from the SAP and RGG domains (<xref rid="figs3" ref-type="fig">FigureÂ S3</xref>A), suggesting the SPRY and AAA<sup>+</sup> domains adopt a defined conformation. 3D homology modeling of SAF-A AAA<sup>+</sup> domain (<xref rid="figs3" ref-type="fig">Figures S3</xref>B and S3C) showed the AAA<sup>+</sup> domain has a core Î±Î²Î± nucleotide-binding fold containing highly conserved Walker-A (WA), Walker-B (WB), and a helical subdomain known as the âlid.â The Walker A motif is predicted to be necessary for nucleotide binding, while the Walker B motif is required for nucleotide hydrolysis.<fig id="fig3"><label>FigureÂ 3</label><caption><p>SAF-A Possesses an RNA-Dependent ATPase Activity and Is Actuated by ATP Binding</p><p>(A) Top: Diagram detailing SAF-A domains (SAP, SPRY, AAA<sup>+</sup>, and RGG), Walker A/B motifs, and constructs used in this study. Walker A mutation was K491A while Walker B mutation was D561A. Bottom: Coomassie-stained SDS-PAGE of purified SAF-A AAA<sup>+</sup> protein.</p><p>(B) Left: ATPase or GTPase activity of recombinant wild-type SAF-A AAA<sup>+</sup> domain and Walker A (deficient in ATP binding) or Walker B (deficient in ATP hydrolysis) SAF-A AAA<sup>+</sup> mutants. Right: ATPase activity of SAF-A AAA<sup>+</sup>/RGG protein fragment with added total RNA or following RNase treatment. Error bars are SEM for three technical replicates; data is representative of two biological experiments.</p><p>(C) Fluorescence spectroscopy (Ex 290Â nm/Em 360Â nm) of SAF-A AAA<sup>+</sup> protein (blue) or Walker A (red) or Walker B (green) mutants with increasing concentrations of ATP. Data is representative of two biological replicates.</p><p>(D) Cartoon of ATP-DnaA complex showing interactions between neighboring AAA<sup>+</sup> modules (purple) to form a helical filament. Image modified from (<xref rid="bib17" ref-type="bibr">Erzberger and Berger, 2006</xref>).</p><p>See also <xref rid="figs3" ref-type="fig">FigureÂ S3</xref>.</p></caption><graphic xlink:href="gr3"/></fig><fig id="figs3"><label>FigureÂ S3</label><caption><p>Structural Characteristics of SAF-A and Identification of Walker and Initiator-Specific Motifs, Related to <xref rid="fig3" ref-type="fig">FigureÂ 3</xref></p><p>(A) SAF-A encodes four conserved domains: SAP (SAF-A/B, Acinus and PIAS) (<xref rid="bib1" ref-type="bibr">Aravind and Koonin, 2000</xref>) which has DNA binding activity (<xref rid="bib24" ref-type="bibr">GÃ¶hring etÂ al., 1997</xref>), SPRY (Spla and Ryanodine receptor) of unknown function (<xref rid="bib48" ref-type="bibr">Ponting etÂ al., 1997</xref>), AAA+ (ATPases Associated with diverse cellular Activities) (<xref rid="bib17" ref-type="bibr">Erzberger and Berger, 2006</xref>), and a low complexity RGG (arginine glycine-glycine) RNA-binding domain (<xref rid="bib30" ref-type="bibr">Helbig and Fackelmayer, 2003</xref>, <xref rid="bib57" ref-type="bibr">Thandapani etÂ al., 2013</xref>). Probability of protein disorder across SAF-A calculated using different algorithms. Amino acid number is given on x axis while y axis depicts the levels of protein disorder.</p><p>(B) Sequence and structure homology between SAF-A AAA+ domain and mammalian PNK (PDB-3ZVL) structure showing predicted Î± helices, Î² sheets and putative Walker motifs. Conserved amino acids are labeled in red and similar amino acids are marked in yellow.</p><p>(C) Left, predicted ribbon diagram of SAF-A, modeled on PDB-3ZVL, showing putative Walker motifs and ISM. Right, cartoon of SAF-A protein showing key domains and ISM.</p></caption><graphic xlink:href="figs3"/></fig></p>
        <p>We directly tested whether SAF-A AAA<sup>+</sup> domain could hydrolyze ATP or GTP. Purified SAF-A AAA<sup>+</sup> fragment, but not SAF-A Walker A or Walker B mutants, exhibited ATPase activity at 0.15Â nmol ATP hydrolyzed per nmol of SAF-A AAA<sup>+</sup> fragment per min, but no GTPase activity (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>B), similar or higher than other AAA<sup>+</sup> proteins such as DnaA (<xref rid="bib54" ref-type="bibr">Sekimizu etÂ al., 1987</xref>) and ORC (<xref rid="bib36" ref-type="bibr">Klemm etÂ al., 1997</xref>) at 0.017 and 0.27Â nmol ATP hydrolyzed per nmol protein per min, respectively. As the AAA<sup>+</sup> domain is located adjacent to an RNA-binding domain, we speculated that RNA might modulate the SAF-A ATPase activity. A longer fragment of SAF-A encompassing the AAA<sup>+</sup>/RGG domains was purified and the ATPase activity measured in the presence or absence of RNA. Total RNA increased the ATPase activity 2.5 times compared to the absence of RNA (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>B).</p>
        <p>To determine whether SAF-A undergoes a conformation change upon ATP-binding, consistent with protein actuation as for other AAA<sup>+</sup> domain proteins (e.g., DnaA), we measured the change in fluorescence upon nucleotide binding. His-tagged AAA<sup>+</sup> fragments of SAF-A were treated with increasing concentrations of ATP and the quenching of intrinsic fluorescence of tryptophan and tyrosine residues were measured to reveal a pronounced alteration in structure upon nucleoside binding (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>C). Mutation of the Walker A motif abrogated ATP binding but Walker B mutations had no effect; K<sub>d</sub> for ATP binding to wild-type SAF-A and Walker B mutant SAF-A were 38Â Î¼M and 29Â Î¼M, respectively.</p>
        <p>ATP binding triggers a change in AAA<sup>+</sup> domain conformation in other proteins, which then stabilizes subunit-subunit interactions (<xref rid="bib18" ref-type="bibr">Erzberger etÂ al., 2006</xref>). We hypothesized that SAF-A might form an oligomeric complex upon ATP binding. Further analysis of SAF-A revealed an additional predicted Î± helix (aa 512â521) after canonical Î² strand 2. This Î± helix is analogous to the initiator-specific motif (ISM) observed in DnaA and ORC family proteins (<xref rid="bib15" ref-type="bibr">Duderstadt etÂ al., 2011</xref>, <xref rid="bib18" ref-type="bibr">Erzberger etÂ al., 2006</xref>), which guides neighboring AAA domains into a non-planar arrangement, preventing formation of a flat ring (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>D) and required for folding into a spiral oligomer.</p>
      </sec>
      <sec id="sec2.4">
        <title>Biochemical Characterization of SAF-A Oligomers</title>
        <p>To investigate whether SAF-A forms oligomeric chains, we reasoned that protein-protein cross-linkers would stabilize oligomeric SAF-A structures that could then be isolated fromÂ cells. To minimize the likelihood of purifying protein aggregates, we treated cells with cross-linkers with amino acid specificity (BM(PEG)2 [1,8-bismaleimido-diethyleneglycol], Cys-Cys, 14.7Â Ã; DSS [disuccinimidyl suberate], Lys-Lys, 11.4Â Ã; GMBS [N-Î³-maleimidobutyryl-oxysuccinimide ester], Cys-Lys, 7.3Â Ã). In contrast to aggregates, oligomeric structures have geometric regularity, so it is less likely that a defined cross-linker will stabilize an aggregate structure. After protein extraction and denaturation, high molecular weight SAF-A species were observed with all cross-linkers consistent with protein oligomerization (<xref rid="fig4" ref-type="fig">Figures 4</xref>A and <xref rid="figs4" ref-type="fig">S4</xref>A). Transcription inhibition substantially reduced oligomer formation (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>A) suggesting that SAF-A oligomerization is transcription-dependent. To identify critical domains for SAF-A oligomerization, individual FLAG-tagged fragments were expressed in cells, cross-linked, and isolated. The AAA<sup>+</sup>/RGG domain efficiently formed oligomers (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>B) while the SPRY domain was refractory to oligomerization; the RGG RNA binding domain was absolutely required (<xref rid="figs4" ref-type="fig">FigureÂ S4</xref>B). In the presence of either ATP or the non-hydrolysable analog ATPÎ³S, the SAF-A AAA<sup>+</sup>/RGG formed high molecular weight oligomeric species indicating that ATP binding maintains the oligomeric form (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>B). In contrast, a AAA<sup>+</sup>/RGG Walker A mutant that is unable to bind ATP showed much less oligomerization, while Walker B mutant fragment-deficient in ATP hydrolysis function stably formed oligomers. These results support the idea that SAF-A undergoes protein oligomerization and hydrolysis similar to DnaA (<xref rid="bib14" ref-type="bibr">Duderstadt etÂ al., 2010</xref>).<fig id="fig4"><label>FigureÂ 4</label><caption><p>ATP- and RNA-Dependent SAF-A Oligomerization Cycle</p><p>(A) Left: Western blot for endogenous SAF-A protein extracted from 293T cells treated with or without Î±-amanitin and stabilized by cross-linking with different concentrations of 1,8-bismaleimido-diethyleneglycol (BM(PEG)2). Proteins were resolved by SDS-PAGE to reveal different SAF-A species (oligomer; D-dimer; M-monomer). Right: Quantification of data in left panel.</p><p>(B) Left: Western blot for FLAG-tagged SAF-A AAA<sup>+</sup>/RGG protein expressed in 293T cells and stabilized with different concentrations of disuccinimidyl suberate (DSS). Extracted proteins were resolved by SDS-PAGE. Right: SAF-A wild-type, Walker A, or Walker B mutants expressed in 293T cells, treated with ATP or ATPÎ³S and cross-linked with 0.3Â mM BM(PEG)2, extracted, and resolved by SDS-PAGE.</p><p>(C) 293T cells expressing full-length FLAG-tagged SAF-A pulse-labeled with 5-ethynyl uridine (5-EU) and stabilized with BM(PEG)2. SAF-A was extracted, immuno-purified and resolved by native PAGE. Left: Western blot for SAF-A. Right: RNA detection in SAF-A oligomers. Samples were fractionated by native gel electrophoresis, transferred to membrane, and RNA was labeled by conjugating biotin to pre-incorporated 5-EU using click chemistry and detection using avidin-HRP.</p><p>(D) Western blot for endogenous SAF-A to analyze protein oligomerization. 293T cells pre-treated with RNaseA, then incubated in the presence or absence of total RNA or apyrase and stabilized by cross-linking with BM(PEG)2. Proteins were extracted and resolved by SDS-PAGE (oligomer; D-dimer; M-monomer).</p><p>(E) Western blot for FLAG-SAF-A to analyze protein de-oligomerization. Cells were cross-linked with dithio-bis-maleimidoethan (DTME) and stabilized SAF-A was immuno-purified. Cross-links were reversed with DTT, then incubated in the presence of RNase, apyrase, or nucleotides and fractionated by native PAGE.</p><p>(F) Model for the ATP- and RNA-dependent SAF-A (purple) oligomerization cycle.</p><p>See also <xref rid="figs4" ref-type="fig">FigureÂ S4</xref>.</p></caption><graphic xlink:href="gr4"/></fig><fig id="figs4"><label>FigureÂ S4</label><caption><p>Role of SAF-A Domains in Protein Oligomerization, Related to <xref rid="fig4" ref-type="fig">FigureÂ 4</xref></p><p>(A) western blot for endogenous SAF-A protein in 293T cells cross-linked with increasing concentrations of 1,8-bismaleimido-diethyleneglycol (BM(PEG)2), disuccinimidyl suberate (DSS), N-Î³-maleimidobutyryl-oxysuccinimide ester (GMBS) and fractionated by SDS-PAGE (Oligomer; D-dimer; M-monomer).</p><p>(B) western blot for FLAG-tagged SAF-A domains (AAA+; AAA+/RGG; SPRY/AAA+; SPRY/AAA+/RGG) expressed in 293T cells, cross-linked using disuccinimidyl suberate (DSS) and fractionated by SDS-PAGE (Oligomer; D-dimer; M-monomer).</p></caption><graphic xlink:href="figs4"/></fig></p>
        <p>To investigate the molecular basis for cyclical SAF-A oligomerization and hydrolysis, we sought to identify the components involved. Guided by the known DnaA interaction with DNA, we purified oligomeric SAF-A (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>C, left) to identify whether it bound to RNA. We found that newly synthesized RNA specifically bound to oligomeric SAF-A (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>C, right) supporting the idea that SAF-A and RNA form a complex. To analyze the steps required for SAF-A oligomerization, we pre-treated cells with RNaseA to monomerize SAF-A (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>D). Addition of total RNA before cross-linking promoted SAF-A oligomerization, which could be abrogated by apyrase treatment showing thatÂ SAF-A oligomerization requires both RNA and ATP. To test SAF-A de-oligomerization, we purified cross-linked oligomeric SAF-A from cells and reversed the cross-links using DTT (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>E). ATP or ATPÎ³S stabilized the oligomers whereas RNase or apyrase treatment promoted monomerization. Together, our data show that SAF-A can undergo cycles of oligomerization promoted by RNA and ATP binding and ATP hydrolysis (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>F).</p>
      </sec>
      <sec id="sec2.5">
        <title>SAF-A Forms Oligomers InÂ Vivo</title>
        <p>To investigate SAF-A dynamics in live cells, we used three complimentary approaches. First, to assay full-length SAF-A oligomerization in cells, we designed a proximity ligation assay (PLA) to detect SAF-A â SAF-A interactions (<xref rid="figs5" ref-type="fig">FigureÂ S5</xref>A). In PLA, proteins are detected with antibodies fused to DNA oligos: close proximity of the proteins allows ligation of the DNA oligos, which can then be amplified and detected by a fluorescent signal. Flp-In T-REx 293 cells were depleted of endogenous SAF-A and then doxycycline treated to express wild-type FLAG-tagged SAF-A or Walker A or Walker B mutants, at a physiological level (<xref rid="figs5" ref-type="fig">FigureÂ S5</xref>B), and co-transfected with T7-tagged full-length SAF-A or SAF-A with Walker A or Walker B point mutations. PLA signals indicating SAF-A interactions (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>A) were found in cells expressing wild-type SAF-A orÂ the SAF-A Walker B mutant, while no interactions were observed for the SAF-A Walker A mutant, suggesting that SAF-A oligomerizes inÂ vivo through ATP binding, while ATP hydrolysis is not important for these associations. We next investigated if transcription regulates SAF-A oligomerization in live cells, consistent with its role upstream of SAF-A in model 1 (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>). To directly test this we treated cells with the transcription inhibitor Î±-amanitin and assayed for SAF-A oligomerization by PLA. After transcription inhibition the number of PLA signals significantly decreased (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>B), concomitant with a reduction in SAF-A oligomeric forms (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>A).<fig id="fig5"><label>FigureÂ 5</label><caption><p>ATP and Transcription-Dependent SAF-A Oligomerization in Cells</p><p>(A) Left: Proximity ligation assay (PLA) signals in Flp-In T-REx 293 cells depleted of endogenous SAF-A (48Â hr) and then doxycycline induced for 24Â hr to express FLAG-tagged wild-type SAF-A or Walker A or Walker B mutants and co-expressing T7-tagged wild-type or mutant versions of SAF-A. Scale bar, 10Â Î¼m. Right: Quantification of PLA signals. p values are for a Wilcoxon test, n &gt; 30 nuclei for two biological replicates.</p><p>(B) Boxplot showing number of PLA signals as in (A) for cells treated in the presence or absence of Î±-amanitin (5Â hr treatment). p values for a Wilcoxon test, nÂ = 30 nuclei for two biological replicates.</p><p>(C) Model depicting the change in FÃ¶rster resonance energy transfer (FRET) efficiency between monomeric and oligomeric forms of GFP-SAF-A (green) and mCherry-SAF-A (red).</p><p>(D) Left: Representative confocal images of 293T cells expressing truncated forms of SAF-A: GFP- AAA<sup>+</sup>/RGG or both mCherry-AAA<sup>+</sup>/RGG and GFP-AAA<sup>+</sup>/RGG. Pseudo-colored images show FRET efficiency calculated from fluorescence-lifetime imaging microscopy (FLIM) of individual pixels (see the <xref rid="sec4" ref-type="sec">STAR Methods</xref>). Right: Boxplot quantifying average FRET efficiency in GFP-AAA<sup>+</sup>/RGG (green) or GFP-AAA<sup>+</sup>/RGG and mCherry-AAA<sup>+</sup>/RGG (red) cells. p values for Studentâs t test, n &gt; 20 nuclei.</p><p>(E) Bar graph of median pixel-by-pixel FRET efficiency in 293T cells expressing GFP-AAA<sup>+</sup>/RGG (green) or GFP-AAA<sup>+</sup>/RGG and mCherry-AAA<sup>+</sup>/RGG (red). Left: Control cells or cells treated with the transcription inhibitors Î±-amanitin or flavopiridol. Right: 293T cells depleted of endogenous SAF-A and expressing GFP- and mCherry-tagged wild-type, Walker A, or Walker B SAF-A mutants. p values for Studentâs t test.</p><p>(F). Super-resolution STED microscopy of FLAG-tagged SAF-A protein. Flp-In T-REx 293 cells depleted of endogenous SAF-A (48Â hr) and then doxycycline induced to express wild-type or mutant Walker A or Walker B SAF-A and counterstained with DRAQ7. Scale bar, 10Â Î¼m. Insets show detail.</p><p>p values: NS, not significant; <sup>âââ</sup>pÂ &lt; 0.001; <sup>ââââ</sup>pÂ &lt; 0.0001.</p><p>See also <xref rid="figs5" ref-type="fig">FigureÂ S5</xref>.</p></caption><graphic xlink:href="gr5"/></fig><fig id="figs5"><label>FigureÂ S5</label><caption><p>PLA and FLIM-FRET Controls to Analyze SAF-A Interactions, Related to <xref rid="fig5" ref-type="fig">FigureÂ 5</xref></p><p>(A) Cartoon representing proximity ligation assay (PLA) to analyze protein-protein associations in cells.</p><p>(B) western blot for FLAG-tagged wild-type, Walker A or Walker B mutant SAF-A and endogenous SAF-A in Flp-In T-Rex 293 cell lines induced by doxycycline. GAPDH was used as a loading control.</p><p>(C) western blot for GFP-tagged full length or AAA+/RGG domain SAF-A expressed in 293T cells, cross-linked using 1,8-bismaleimido-diethyleneglycol (BM(PEG)2) and fractionated by SDS-PAGE.</p><p>(D) Representative confocal images under different experimental conditions in 293T cells expressing fluorescently tagged forms of SAF-A: GFP-AAA+/RGG or GFP-AAA+/RGG with free mCherry or cells expressing both mCherry-AAA+/RGG and GFP-AAA+/RGG and pseudo-colored images showing FRET efficiency calculated from fluorescence-lifetime imaging microscopy (FLIM) of individual pixels. Right, distribution of pixel FRET efficiency for multiple (5 â 20) nuclei.</p><p>(E) Calibration of STED microscopy using 20-nm fluorescent beads. Scale bar, 500Â nm.</p><p>(F) Super-resolution STED and confocal microscopy of FLAG-tagged wild-type SAF-A or SAF-A Walker A or Walker B mutants in Flp-In T-Rex 293 cells. Cells were depleted of endogenous SAF-A and FLAG tagged proteins induced by doxycycline treatment. Cells were counterstained with DRAQ7. Scale bar, 10Â Î¼m.</p><p>(G) Left, boxplot showing SAF-A granules per nucleus in FLAG-tagged wild-type SAF-A or SAF-A Walker A or Walker B mutants as in <xref rid="fig5" ref-type="fig">FigureÂ 5</xref>F and (E). P values for a Wilcoxon test (n &gt; 30 nuclei; <sup>ââââ</sup>pÂ &lt; 0.0001). Right, density plot showing mean SAF-A granule intensity in nuclei expressing wild-type or mutant SAF-A (n &gt; 30 nuclei for each sample).</p></caption><graphic xlink:href="figs5"/></fig></p>
        <p>Second, we analyzed SAF-A interactions using FLIM-FRET (fluorescence lifetime imaging microscopy â FÃ¶rster resonance energy transfer). FLIM-FRET is a well-established approach to detect interactions at the nanometer scale (<xref rid="bib38" ref-type="bibr">LlÃ¨res etÂ al., 2017</xref>); we predicted that SAF-AâSAF-A interactions in oligomers should be detectable by FRET (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>C). Although fluorescent protein tags inhibited the oligomerization of the full-length protein, oligomerization could be observed biochemically for GFP and mCherry-tagged AAA<sup>+</sup>/RGG SAF-A fragments (<xref rid="figs5" ref-type="fig">FigureÂ S5</xref>B). We expressed the GFP-tagged AAA<sup>+</sup>/RGG fragment in cells, either on its own (donor only) or in combination with a mCherry-tagged version of the same fragment and measured the fluorescence lifetime of GFP. An interaction between the two differentially labeled fragments is expected to result in energy transfer between the GFP and mCherry tags, associated with a decrease in the fluorescence lifetime of GFP. The difference in GFP lifetime between the donor alone (GFP fragment on its own) and the FRET conditions can then be expressed as FRET efficiency. We found a significant increase in FRET efficiency in cells expressing both GFP and mCherry tagged AAA<sup>+</sup>/RGG fragments, strongly indicative of oligomerization involving the two components (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>D). Consistently with the PLA data, a decrease in FRET efficiency was observed for AAA<sup>+</sup>/RGG Walker A mutant fragments, confirming the importance of ATP binding for oligomerization (<xref rid="fig5" ref-type="fig">Figures 5</xref>E and <xref rid="figs5" ref-type="fig">S5</xref>C). Fragments carrying Walker B mutations resulted in an increase in FRET efficiency compared to theÂ wild-type, suggesting a defect in the oligomerization cycle and underscoring the role of ATP hydrolysis in SAF-A monomerization. Abolishing transcription, using two different inhibitors, also impeded oligomerization, as evidenced by a decrease in FRET efficiency (<xref rid="fig5" ref-type="fig">Figures 5</xref>E and <xref rid="figs5" ref-type="fig">S5</xref>C).</p>
        <p>Finally, as the FLIM-FRET analysis indicated that the Walker B mutant showed excessive oligomerization, we speculated that ATP hydrolysis might be important for the reversal and dynamics of this process. Consistently, when we examined the staining patterns of FLAG-tagged wild-type SAF-A and the two mutants by super-resolution STED microscopy (<xref rid="figs5" ref-type="fig">FigureÂ S5</xref>D), the SAF-A Walker B mutant showed a granular staining pattern indicative of large SAF-A oligomers, which was not observed in the wild-type SAF-A or the SAF-A Walker A mutant (<xref rid="fig5" ref-type="fig">Figures 5</xref>F and <xref rid="figs5" ref-type="fig">S5</xref>E). Quantification of the granules showed that the Walker B mutant had significantly more and brighter granules than for either wild-type or Walker A mutant (<xref rid="figs5" ref-type="fig">FigureÂ S5</xref>F), highly indicative of SAF-A Walker B mutant oligomers continuing to undergo oligomerization, forming large structures. These three pieces of evidence support a model of cyclical SAF-A oligomerization and monomerization in response to transcription and regulated by ATP binding and hydrolysis.</p>
      </sec>
      <sec id="sec2.6">
        <title>SAF-A Regulates Chromatin Structure through caRNAs</title>
        <p>We next tested whether SAF-A oligomerization was required for regulation of large-scale chromatin structures by examining 11p15.5 (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B) or 2p25.1 (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>A) compaction following rescue experiments with RNAi-resistant wild-type SAF-A, or SAF-A encoding Walker A or Walker B mutants at different time points (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>A, colored triangles). As predicted, wild-type SAF-A was able to rescue the compacted phenotype and efficiently decompact chromatin (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B, box 3). Expression of the Walker A mutant was unable to rescue the chromatin state (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B, box 5) showing that SAF-A oligomerization is required for chromatin decompaction. Conversely, the Walker B mutant was able to decompact the gene-rich region (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B, box 7), indicating that oligomerization, and not the dynamic cycling between oligomeric and monomeric states, is essential for decompacting large-scale chromatin structure. In the opposite experiment, we tested whether SAF-A monomerization was necessary for chromatin compaction, taking advantage of the ability of Î±-amanitin to compact chromatin (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>F): expression of the SAF-A protein in the presence of Î±-amanitin (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B, box 8) was able to drive chromatin compaction (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B, box 4), however, the Walker B mutant was unable to drive chromatin compaction (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B, box 8) consistent with ATP-hydrolysis being required to cycle from an oligomeric to monomeric state to compact chromatin. Thus, we conclude that SAF-A oligomer assembly and disassembly regulates large-scale chromatin structure.<fig id="fig6"><label>FigureÂ 6</label><caption><p>SAF-A Oligomerization Regulates Interphase Chromosome Structure via Chromatin-Associated RNAs</p><p>(A) Top: Model for chromatin decompaction by SAF-A oligomerization. Bottom: Experimental strategy to test model. Flp-In T-REx 293 cells depleted of endogenous SAF-A (48Â hr) and then doxycycline-induced for 24Â hr to express wild-type or mutant SAF-A. Samples were taken at times (colored triangles) for analysis.</p><p>(B) Boxplots showing the distribution of distances between probe pairs at 11p15.5 from a FISH chromatin compaction assay in cells before (0Â hr, red rectangle, box 1), after SAF-A depletion (siSAF-A, dark orange rectangle, box 2), and after re-expression of siRNA-resistant wild-type SAF-A, Walker A, or Walker B mutants in the absence (pale orange rectangles, boxes 3, 5, 7) or presence (green rectangles, boxes 4, 6, 8) of Î±-amanitin (nÂ = 100 for two biological replicates). Colored bars correspond to time points shown in (A).</p><p>(C) Model depicting direct or indirect binding of SAF-A (purple) to chromatin (blue) in the presence of caRNAs (red).</p><p>(D) Left: Western blot showing extraction of SAF-A into soluble and insoluble fractions from cells before and after treatment with RNase A/T1 or DNaseI. Right: Western blot showing FLAG-tagged full length SAF-A or SAF-A truncated at the N (ÎSAP) or C (ÎRGG) termini extracted into soluble and insoluble fractions.</p><p>(E) Boxplots as described in (B) showing effect of re-expressing SAF-A lacking the RGG-domain on large scale chromatin compaction. Colored bars correspond to time points in (A).</p><p>p values for a Wilcoxon test: NS, not significant; <sup>ââââ</sup>pÂ &lt; 0.0001.</p><p>See also <xref rid="figs6" ref-type="fig">FigureÂ S6</xref> and <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>.</p></caption><graphic xlink:href="gr6"/></fig><fig id="figs6"><label>FigureÂ S6</label><caption><p>SAF-A Oligomerization Regulates Interphase Chromatin Structure via Chromatin-Associated RNAs but Is Not Required to Maintain C<sub>0</sub>t1 and LINE-1 RNA, Related to <xref rid="fig6" ref-type="fig">FigureÂ 6</xref></p><p>(A) Boxplots showing the distribution of distances between probe pairs at 2p25.1 from a FISH chromatin compaction assay in cells before (0Â hr, red rectangle, boxÂ 1), after SAF-A depletion (siSAF-A, dark orange rectangle, box 2) and after re-expression of siRNA-resistant wild-type SAF-A, Walker A or Walker B mutants in the absence (pale orange rectangles, box 3, 5, 7) or presence (green rectangles, box 4, 6, 8) of Î±-amanitin (n &gt; 100). Colored bars correspond to time points shown in <xref rid="fig6" ref-type="fig">FigureÂ 6</xref>A.</p><p>(B) Immunofluorescence for SAF-A in Triton X-100 extracted RPE1 cells treated with RNaseA/T1, counterstained with DAPI. Scale bar, 10Î¼m.</p><p>(C) DNA-FISH for human chromosome 3 (HSA3, C<sub>0</sub>t1 DNA probe) in a human-hamster hybrid cell line (GM10253A) that stably carries HSA3 in conjunction with RNA-FISH to assay for the binding and distribution of caRNAs (C<sub>0</sub>t1 RNA probe) or LINE-1 ORF2 RNA in control cells (siControl) and cells depleted for SAF-A (siSAF-A) and cells treated with the transcription inhibitors Î±-amanitin or actinomycin D. Scale bars, 10Â Î¼m.</p><p>(D) Boxplot showing area occupied by HSA3 territory (C<sub>0</sub>t1 DNA probe) as in panel C in GM10253A control cells (siControl), cells depleted for SAF-A (siSAF-A) and cells treated with the transcription inhibitors Î±-amanitin or actinomycin D (5 h). P values for a Wilcoxon test (n &gt; 30 nuclei; <sup>ââââ</sup>pÂ &lt; 0.0001).</p><p>(E) Fluorescence microscopy in RPE1 cells pre-treated with low dose (50Â ng/ml) actinomycin D (60Â min) and pulse labeled (15Â min) with 5-ethynyl uridine (5-EU), fixed at the indicated time post 5-EU treatment. 5-EU was conjugated to Cy5 in a click chemistry reaction for visualization.</p><p>(F) Top left, dot blotting of RNA co-purified with FLAG-tagged full length SAF-A or SAF-A truncated at the C terminus to remove the RGG domain; Flp-In T-REx 293 cells were doxycycline induced for 24Â hr to express wild-type or mutant SAF-A. RNA was labeled (15Â min) with 5-EU followed by crosslinking with BM(PEG)2 and immune-purified with FLAG antibody, and conjugated using click chemistry with a biotin azide and detected by streptavidin-conjugated horseradish peroxidase and chemiluminescence. Top right, dot blot showing RNA co-purified with FLAG-tagged full length SAF-A. Bottom, quantification of 5-EU and RNA signals shown in panel E and F.</p></caption><graphic xlink:href="figs6"/></fig></p>
        <p>We next addressed how SAF-A interacted with chromatin to regulate large-scale chromatin structures. We hypothesized two potential modes of interaction: SAF-A could either be directly bound to chromatin, or it might bind indirectly, interacting with RNAs (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>B) through the RGG domain (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>A). In pilot experiments, we found that unlike positive controls, DNAÂ was not co-precipitated in chromatin immunoprecipitation (ChIP) assays with antibodies against SAF-A, suggesting the protein was not directly bound toÂ chromatin. In contrast, cross-linking immunoprecipitation sequencing (CLIP-seq) experiments have shown that SAF-A is able to bind to virtually all classes of regulatory RNA (<xref rid="bib59" ref-type="bibr">Xiao etÂ al., 2012</xref>).To analyze the mode of SAF-A binding, nuclear samples were treated with RNaseA/T1 or DNaseI before extraction into a soluble and insoluble (chromatin-associated) state; RNase treatment significantly abolished SAF-A chromatin binding, while DNaseI only had a limited effect (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>D). To further explore the mechanics of SAF-A/RNA interaction with chromatin, we used an approach developed by <xref rid="bib28" ref-type="bibr">Hall etÂ al. (2014)</xref> based on the observation that caRNAs, detected by RNA-FISH with a human C<sub>0</sub>t1 probe in human-hamster hybrids, remain associated with the chromosome territory from where they are transcribed, in an unstable manner (t<sub>1/2</sub>Â = 1Â hr, <xref rid="figs6" ref-type="fig">FigureÂ S6</xref>E). SAF-A depletion did not affect C<sub>0</sub>t1 RNA binding to chromosomes (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>C) while transcription inhibition triggered a rapid loss of C<sub>0</sub>t1 orÂ LINE-1 signal and chromosome territory compaction (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>D), consistent with SAF-A binding to chromatin via caRNAs. We also found that SAF-A bound to newly transcribed caRNA through its RGG domain (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>F) and further tested whether this binding was required for chromatin decompaction using the approach developed in <xref rid="fig6" ref-type="fig">FigureÂ 6</xref>A. Re-expression of SAF-A ÎRGG was unable to decompact chromatin structures (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>E) indicating that SAF-A oligomerization regulates large-scale chromatin structures through an interaction with caRNAs.</p>
      </sec>
      <sec id="sec2.7">
        <title>SAF-A Is Required for Chromosome Stability</title>
        <p>Unexpectedly, our data indicates that altering large-scale chromatin structure, by depletion of SAF-A, only has limited impact on transcription (<xref rid="fig2" ref-type="fig">Figures 2</xref> and <xref rid="figs2" ref-type="fig">S2</xref>). However, we speculated that interphase chromatin structure disruption would have an effect on genome integrity. We observed diffuse phosphorylated H2AX (Î³-H2AX) signals in SAF-A-depleted RPE1 cells (<xref rid="figs7" ref-type="fig">FigureÂ S7</xref>A), a response reflective of nuclear stress (<xref rid="bib42" ref-type="bibr">Meyer etÂ al., 2013</xref>). Diffuse Î³-H2AX signals appeared 48Â hr after an alteration in large-scale chromatin structure suggesting that irregular chromatin triggers the response. We also characterized the effect of Walker A or Walker B mutations on genomic stability: only the oligomerization-deficient Walker A mutant promoted the accumulation of diffuse Î³-H2AX pattern (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>A) suggesting that inhibition of oligomerization and enforced chromatin compaction triggers a response, indicative of cellular mechanisms that monitor chromatin structure integrity. Spiral-shaped and distorted metaphase chromosomes were also observed in SAF-A-depleted cells, which also showed reduction in viability, G1/S phase arrest (<xref rid="fig7" ref-type="fig">Figures 7</xref>B and 7C), chromosomal segregation defects, and the formation of anaphase bridges staining positive for the BLM protein (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>C). To assess the long-term impact of an alteration in chromatin structure on chromosomal instability, we performed chromosome painting FISH for HSA2 and HSA4 (<xref rid="figs7" ref-type="fig">FigureÂ S7</xref>D). Control cells predominantly had two copies of HSA2 and HSA4 while 25% and 21%, respectively, have more than three chromosome signals after the depletion of SAF-A, indicating that an alteration in interphase chromatin structure causes chromosomal instability. A similar effect could be observed in cells expressing the SAF-A Walker A mutant, but not the Walker B mutant, indicating that large-scale chromatin structure, regulated by SAF-A oligomerization, is essential for chromosome stability (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>D).<fig id="fig7"><label>FigureÂ 7</label><caption><p>Disruption of SAF-A-Dependent Large-Scale Chromatin Structure Causes Genome Instability</p><p>(A) Quantification of the frequency of diffuse and focal Î³-H2AX signals. Flp-In T-REx 293 cells were depleted of endogenous SAF-A (48Â hr) and then doxycycline induced for 24Â hr to express wild-type or mutant SAF-A.</p><p>(B) Top: Representative images of mitotic chromosomes prepared from RPE1 cells (siControl) or cells depleted of SAF-A (siSAF-A) and stained with DAPI. Scale bars, 5Â Î¼m. Bottom: Quantification of chromosome morphology.</p><p>(C) Frequency of anaphase bridges observed after staining with BLM in RPE1 cells (siControl, nÂ = 53) or cells depleted of SAF-A (siSAF-A, nÂ = 39).</p><p>(D) Top: DNA FISH for human chromosome 2 (HSA2) and 4 (HSA4) territories in Flp-In T-REx 293 cells depleted of endogenous SAF-A, with wild-type or Walker A or B SAF-A mutants re-expressed. Nuclei were counterstained with DAPI (blue). Scale bars, 10Â Î¼m. Bottom: Quantification of chromosome territory number for HSA2 and HSA4 (n &gt; 150 nuclei; p values for a chi-square test).</p><p>See also <xref rid="figs7" ref-type="fig">FigureÂ S7</xref>.</p></caption><graphic xlink:href="gr7"/></fig><fig id="figs7"><label>FigureÂ S7</label><caption><p>Characterization of Genome Instability and Distribution of SAF-A Cancer Mutations, Related to <xref rid="fig7" ref-type="fig">FigureÂ 7</xref></p><p>(A) Left, immunofluorescence staining for Î³-H2AX in RPE1 control cells (siControl) or cells depleted of SAF-A (siSAF-A). Scale bar, 10Â Î¼m. Right, quantification of the frequency of diffuse and focal Î³-H2AX signals, data representative of two biological replicates.</p><p>(B) Growth curve for RPE1 cells (siControl) and cells depleted of SAF-A (siSAF-A) across a 72Â hr time period.</p><p>(C) Cell cycle profile for control cells (siControl) and cells knocked down for SAF-A (siSAF-A). After knock-down cells were synchronized using aphidicolin for 24Â hr and released. Aliquots were taken at 0, 2, 4, 6Â hr, stained with propidium iodide and the DNA content analyzed by flow cytometry.</p><p>(D) Left, FISH for human HSA2 and HSA4 chromosome territories in RPE1 control cells (siControl) or cells depleted of SAF-A (siSAF-A). Scale bar, 10Â Î¼m. Right, quantification of chromosome territory number for HSA2 and HSA4 (n &gt; 75, p values are for a Chi squared test).</p><p>(E) Left, distribution of SAF-A AAA+ mutations from COSMIC (Catalogue Of Somatic Mutations In Cancer) in the SAF-A AAA+ domain. Right, diagram showing position of the AAA+ lid domain.</p></caption><graphic xlink:href="figs7"/></fig></p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>Discussion</title>
      <p>We have demonstrated a previously unknown role for the abundant nuclear protein SAF-A in regulating interphase chromosome structure via oligomerization with caRNAs. ATP binding through the SAF-A AAA<sup>+</sup> domain mediates oligomerization, while the RNA-binding domain of SAF-A directly links protein assembly with caRNAs. Our preliminary data indicates that caRNAs have a short half-life (â¼1Â hr) in the nucleus, and the caRNA pool is rapidly turned over suggesting that caRNAs should be considered as a dynamic nuclear compartment that is involved in chromatin structure regulation. It is therefore possible that caRNAs, generated by normal transcription, decompact large-scale chromatin structures facilitating their transport from the nucleus.</p>
      <p>Expanding both the classical concept of a nuclear matrix underpinning interphase chromatin domains and more recent observations of RNA as a fundamental chromatin component (<xref rid="bib27" ref-type="bibr">Hall and Lawrence, 2016</xref>), we suggest that SAF-A, together with heterogeneous caRNAs forms a dynamic chromatin mesh that regulates chromatin structure. Unlike previously envisioned static models of the nuclear matrix, this process is dynamic and responsive to transcription. From our studies, it is not clear what structure SAF-A adopts. However, the protein shows compelling similarity to DnaA protein, and the presence of an ISM suggests it might be a spiral oligomer (<xref rid="bib18" ref-type="bibr">Erzberger etÂ al., 2006</xref>). The underlying regulatory mechanisms for triggering SAF-A oligomerization are unclear, but SAF-A has a number of predicted phosphorylation sites and interacts with known kinases (<xref rid="bib8" ref-type="bibr">Britton etÂ al., 2014</xref>, <xref rid="bib13" ref-type="bibr">Douglas etÂ al., 2015</xref>). In addition, a SAF-A homolog, HNRNPUL1, shows 60% similarity, but there is no evidence for the presence of a Walker A or Walker B motif raising the possibility that it might function as a regulatory protein to âcapâ growing SAF-A chains.</p>
      <p>An insight into the functional interplay between SAF-A and chromatin could be provided by recent simulation experiments suggesting that non-specific binding-induced-attraction is sufficient to generate local chromatin domains or chromatin micro-bodies (<xref rid="bib7" ref-type="bibr">Brackley etÂ al., 2016</xref>). Formation is driven by protein-chromatin interactions mediated by RNA that could partition the genome into functionally open or closed domains, observed by chromosome conformation capture techniques, providing an evolutionary constraint for maintaining gene-rich domains together (<xref rid="bib21" ref-type="bibr">Ghanbarian and Hurst, 2015</xref>). Surprisingly, this model does not require explicit boundary elements suggesting that evolutionary domains could divide or merge depending on local transcription. It is also tempting to speculate that transcription ripples that occur over 100 kb in mammalian cells could limit the maximum size of functional domains (<xref rid="bib16" ref-type="bibr">Ebisuya etÂ al., 2008</xref>). The regulation of chromatin micro-bodies is unknown but could be regulated by the cyclical ATP-dependent polymerization of SAF-A, while extensive RNA-chromatin interactions will provide a âglueâ to stabilize local chromatin structures.</p>
      <p>Previous reports show that SAF-A is essential for mouse embryonic development (<xref rid="bib51" ref-type="bibr">Roshon and Ruley, 2005</xref>, <xref rid="bib60" ref-type="bibr">Ye etÂ al., 2015</xref>), and numerous mutations have been reported in the AAA<sup>+</sup> domain of SAF-A in the cancer genome sequencing projects with a pronounced cluster in the AAA<sup>+</sup> lid domain (<xref rid="figs7" ref-type="fig">FigureÂ S7</xref>E). It has also recently been reported that haploinsufficiency for SAF-A causes impaired neurological development in humans (<xref rid="bib12" ref-type="bibr">Deciphering Developmental Disorders Study, 2015</xref>). Consistent with these pathological effects, our data shows that maintenance of interphase chromosome structure by SAF-A is necessary to maintain chromosome stability and aberrant chromatin structure triggers a DNA damage response (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>). This suggests the mammalian genome has mechanisms for sensing changes in large-scale chromatin structure. This is signaled by an ATM/ATR-dependent response that leads to H2AX phosphorylation and a rapid cell-cycle arrest. While we show that large-scale chromatin structures are secondary to transcription, our data highlights that maintenance of chromosome organization is necessary for chromosome stability, implicating chromatin architecture as a guardian of the genome.</p>
    </sec>
    <sec id="sec4">
      <title>STARâMethods</title>
      <sec id="sec4.1">
        <title>Key Resources Table</title>
        <p>
          <table-wrap id="undtbl1" position="float">
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th>REAGENT or RESOURCE</th>
                  <th>SOURCE</th>
                  <th>IDENTIFIER</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td colspan="3">
                    <bold>Antibodies</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td>anti-FLAG M2 (1:5000 for western blotting, 1:500 for immunofluorescence)</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# F1804; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_262044" id="intref0010">AB_262044</ext-link></td>
                </tr>
                <tr>
                  <td>anti-FLAG M2 Affinity Gel</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# A2220; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_10063035" id="intref0015">AB_10063035</ext-link></td>
                </tr>
                <tr>
                  <td>anti-FLAG (1:500 for PLA)</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# F7425; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_439687" id="intref0020">AB_439687</ext-link></td>
                </tr>
                <tr>
                  <td>anti-T7 (1:500 for PLA)</td>
                  <td>Millipore</td>
                  <td>Cat# 69522</td>
                </tr>
                <tr>
                  <td>anti-GFP (1:5000 for western blotting)</td>
                  <td>Abcam</td>
                  <td>Cat# ab290; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_303395" id="intref0025">AB_303395</ext-link></td>
                </tr>
                <tr>
                  <td>anti-Histone H3 (1:50000 for western blotting)</td>
                  <td>Abcam</td>
                  <td>Cat# ab1791; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_302613" id="intref0030">AB_302613</ext-link></td>
                </tr>
                <tr>
                  <td>anti-Î³-H2AX (1:1000 for immunofluorescence)</td>
                  <td>Millipore</td>
                  <td>Cat# 05-636</td>
                </tr>
                <tr>
                  <td>anti-hnRNP A1 (1:3000 for western blotting)</td>
                  <td>Invitrogen</td>
                  <td>Cat# PA5-19431</td>
                </tr>
                <tr>
                  <td>anti-hnRNP C (1:3000 for western blotting)</td>
                  <td>Santa Cruz</td>
                  <td>Cat# sc32308; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_627731" id="intref0035">AB_627731</ext-link></td>
                </tr>
                <tr>
                  <td>anti-GAPDH (1:5000 for western blotting)</td>
                  <td>Cell Signaling</td>
                  <td>Cat# 2118L; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_561053" id="intref0040">AB_561053</ext-link></td>
                </tr>
                <tr>
                  <td>anti-SAF-A 3G6 (1:5000 for western blotting)</td>
                  <td>Abcam</td>
                  <td>Cat# ab10297</td>
                </tr>
                <tr>
                  <td>anti-SAF-A for IF (1:200 for immunofluorescence)</td>
                  <td>Bethyl</td>
                  <td>Cat# A300-690A</td>
                </tr>
                <tr>
                  <td>anti-Ki67 (1:300 for immunofluorescence)</td>
                  <td>Abcam</td>
                  <td>Cat# ab15580; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_443209" id="intref0045">AB_443209</ext-link></td>
                </tr>
                <tr>
                  <td>anti-sc35 (1:300 for immunofluorescence)</td>
                  <td>Abcam</td>
                  <td>Cat# ab11826; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_298608" id="intref0050">AB_298608</ext-link></td>
                </tr>
                <tr>
                  <td>anti-BLM (1:500 for immunofluorescence)</td>
                  <td>Santa Cruz</td>
                  <td>Cat# sc7790; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_2243489" id="intref0055">AB_2243489</ext-link></td>
                </tr>
                <tr>
                  <td>Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488</td>
                  <td>ThermoFisher</td>
                  <td>Cat# A11029; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_138404" id="intref0060">AB_138404</ext-link></td>
                </tr>
                <tr>
                  <td>Donkey anti-Rabbit Texas Red</td>
                  <td>Jackson ImmunoResearch</td>
                  <td>Cat# 711-075-152</td>
                </tr>
                <tr>
                  <td>Goat anti-Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 647</td>
                  <td>ThermoFisher</td>
                  <td>Cat# A21235; RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_141693" id="intref0065">AB_141693</ext-link></td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <bold>Chemicals, Peptides, and Recombinant Proteins</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td>ExtrAvidinâPeroxidase</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# E2886</td>
                </tr>
                <tr>
                  <td>3X FLAG Peptide</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# F4799</td>
                </tr>
                <tr>
                  <td>Î±-amanitin</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# A2263</td>
                </tr>
                <tr>
                  <td>Flavopiridol</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# F3055</td>
                </tr>
                <tr>
                  <td>Actinomycin D</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# A4262</td>
                </tr>
                <tr>
                  <td>DRB</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# D1916</td>
                </tr>
                <tr>
                  <td>Hygromycin B</td>
                  <td>Roche</td>
                  <td>Cat# 10843555001</td>
                </tr>
                <tr>
                  <td>Puromycin</td>
                  <td>ThermoFisher</td>
                  <td>Cat# A1113803</td>
                </tr>
                <tr>
                  <td>Doxycycline</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# D9891</td>
                </tr>
                <tr>
                  <td>Lipofectamine RNAiMAX Reagent</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 13778150</td>
                </tr>
                <tr>
                  <td>Lipofectamine 2000 Reagent</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 11668019</td>
                </tr>
                <tr>
                  <td>Lipofectamine 3000 Reagent</td>
                  <td>ThermoFisher</td>
                  <td>Cat# L3000015</td>
                </tr>
                <tr>
                  <td>TURBO DNase</td>
                  <td>ThermoFisher</td>
                  <td>Cat# AM2239</td>
                </tr>
                <tr>
                  <td>DNaseI</td>
                  <td>NEB</td>
                  <td>Cat# M0303S</td>
                </tr>
                <tr>
                  <td>Nuclease P1</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# N8630</td>
                </tr>
                <tr>
                  <td>RNase A/T1</td>
                  <td>Ambion</td>
                  <td>Cat# AM2286</td>
                </tr>
                <tr>
                  <td>PureLink RNase A</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 12091039</td>
                </tr>
                <tr>
                  <td>RNasin Plus RNase Inhibitor</td>
                  <td>Promega</td>
                  <td>Cat# N2611</td>
                </tr>
                <tr>
                  <td>Apyrase</td>
                  <td>NEB</td>
                  <td>Cat# M0398S</td>
                </tr>
                <tr>
                  <td>Disuccinimidyl suberate (DSS)</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 21655</td>
                </tr>
                <tr>
                  <td>1,8-bismaleimido-diethyleneglycol (BM(PEG)2)</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 22336</td>
                </tr>
                <tr>
                  <td>N-Î³-maleimidobutyryl-oxysuccinimide ester (GMBS)</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 22309</td>
                </tr>
                <tr>
                  <td>Dithio-bis-maleimidoethane (DTME)</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 22335</td>
                </tr>
                <tr>
                  <td>L-cysteine</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# 168149</td>
                </tr>
                <tr>
                  <td>NuPAGE LDS sample buffer</td>
                  <td>ThermoFisher</td>
                  <td>Cat# NP0007</td>
                </tr>
                <tr>
                  <td>7% tris-acetate gels</td>
                  <td>ThermoFisher</td>
                  <td>Cat# EA03555BOX</td>
                </tr>
                <tr>
                  <td>NuPAGE Tris-Acetate SDS Running Buffer (20X)</td>
                  <td>ThermoFisher</td>
                  <td>Cat# LA0041</td>
                </tr>
                <tr>
                  <td>NuPAGE 4-12% Bis-Tris Protein Gels</td>
                  <td>ThermoFisher</td>
                  <td>Cat# NP0323BOX</td>
                </tr>
                <tr>
                  <td>Bolt 8% Bis-Tris Plus Gels</td>
                  <td>ThermoFisher</td>
                  <td>Cat# NW00085BOX</td>
                </tr>
                <tr>
                  <td>NuPAGE MOPS SDS Running Buffer (20X)</td>
                  <td>ThermoFisher</td>
                  <td>Cat# NP0001</td>
                </tr>
                <tr>
                  <td>NativePAGE 4-16% Bis-Tris Protein Gels</td>
                  <td>ThermoFisher</td>
                  <td>Cat# BN1004BOX</td>
                </tr>
                <tr>
                  <td>NativePAGE Running Buffer Kit</td>
                  <td>ThermoFisher</td>
                  <td>Cat# BN2007</td>
                </tr>
                <tr>
                  <td>NativePAGE Sample Prep Kit</td>
                  <td>ThermoFisher</td>
                  <td>Cat# BN2008</td>
                </tr>
                <tr>
                  <td>Immobilon-P Membrane, PVDF, 0.45Â Î¼m</td>
                  <td>Merck Millipore</td>
                  <td>Cat# IPVH00010</td>
                </tr>
                <tr>
                  <td>SuperSignal West Femto Maximum Sensitivity Substrate</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 34094</td>
                </tr>
                <tr>
                  <td>SuperSignal West Pico Chemiluminescent Substrate</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 34080</td>
                </tr>
                <tr>
                  <td>5-ethynyl uridine (5-EU)</td>
                  <td>BaseClick</td>
                  <td>Cat# BCN-003-5</td>
                </tr>
                <tr>
                  <td>4-thiouridine</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# T4509</td>
                </tr>
                <tr>
                  <td>Thymidine</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# T9250</td>
                </tr>
                <tr>
                  <td>Adenosine 5â²-triphosphate disodium salt hydrate</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# A2383</td>
                </tr>
                <tr>
                  <td>Guanosine 5â²-triphosphate sodium salt hydrate</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# G8877</td>
                </tr>
                <tr>
                  <td>Adenosine 5â²-[Î³-thio]triphosphate tetralithium salt</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# A1388</td>
                </tr>
                <tr>
                  <td>Biotin Azide (PEG4 carboxamide-6-Azidohexanyl Biotin)</td>
                  <td>ThermoFisher</td>
                  <td>Cat# B10184</td>
                </tr>
                <tr>
                  <td>Alexa Fluor 647 Azide, Triethylammonium Salt</td>
                  <td>ThermoFisher</td>
                  <td>Cat# A10277</td>
                </tr>
                <tr>
                  <td>Digoxigenin-11-UTP</td>
                  <td>Roche</td>
                  <td>Cat# 00000001109â3088910</td>
                </tr>
                <tr>
                  <td>Biotin-16-dUTP</td>
                  <td>Roche</td>
                  <td>Cat# 00000001109â3070910</td>
                </tr>
                <tr>
                  <td>DRAQ7</td>
                  <td>Abcam</td>
                  <td>Cat# ab109202</td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <bold>Critical Commercial Assays</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td>Duolink In Situ PLA Probe Anti-Mouse PLUS Affinity purified Donkey anti-Mouse IgG (H+L)</td>
                  <td>ThermoFisher</td>
                  <td>Cat# DUO92001</td>
                </tr>
                <tr>
                  <td>Duolink In Situ PLA Probe Anti-Rabbit MINUS Affinity purified Donkey anti-Rabbit IgG (H+L)</td>
                  <td>ThermoFisher</td>
                  <td>Cat# DUO92005</td>
                </tr>
                <tr>
                  <td>Duolink In Situ Detection Reagents Red</td>
                  <td>ThermoFisher</td>
                  <td>Cat# DUO92008</td>
                </tr>
                <tr>
                  <td>Click-iT EdU Alexa Fluor 647 Imaging Kit (for 5EU labeling)</td>
                  <td>ThermoFisher</td>
                  <td>Cat# C10337</td>
                </tr>
                <tr>
                  <td>Click-iT Nascent RNA Capture Kit</td>
                  <td>ThermoFisher</td>
                  <td>Cat# C10340</td>
                </tr>
                <tr>
                  <td>BIOMOL Green</td>
                  <td>Enzo Life Science</td>
                  <td>Cat# BML-AK111-0250</td>
                </tr>
                <tr>
                  <td>Ribo-Zero rRNA Removal Kit (Human/Mouse/Rat)</td>
                  <td>illumina</td>
                  <td>Cat# MRZH116</td>
                </tr>
                <tr>
                  <td>RNeasy Mini kit</td>
                  <td>QIAGEN</td>
                  <td>Cat# 74104</td>
                </tr>
                <tr>
                  <td>NEBNext Ultr RNA Library Prep Kit for Illumina</td>
                  <td>NEB</td>
                  <td>Cat# E7530S</td>
                </tr>
                <tr>
                  <td>High Sensitivity DNA Kits</td>
                  <td>Agilent Genomics</td>
                  <td>Cat# 5067-4626</td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <bold>Deposited Data</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td>RNA-seq data</td>
                  <td>This paper</td>
                  <td>GEO: <ext-link ext-link-type="uri" xlink:href="ncbi-geo:GSE98541" id="intref0070">GSE98541</ext-link></td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <bold>Experimental Models: Cell Lines</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td>Human: hTERT-RPE1 cell</td>
                  <td>ATCC</td>
                  <td>Cat# ATCC-CRL-4000</td>
                </tr>
                <tr>
                  <td>Human: 293T</td>
                  <td>ATCC</td>
                  <td>Cat# ATCC-CRL-3216</td>
                </tr>
                <tr>
                  <td>Human: FlpIn T-REx 293 Cell line</td>
                  <td>ThermoFisher</td>
                  <td>Cat# R78007</td>
                </tr>
                <tr>
                  <td>Human-Hamster hybrid: GM10253</td>
                  <td>Coriell Institute</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Human: FlpIn T-REx 293 FLAG-SAF-A</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Human: FlpIn T-REx 293 FLAG-SAF-A Walker A mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Human: FlpIn T-REx 293 FLAG-SAF-A Walker B mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Human: FlpIn T-REx 293 FLAG-SAF-A ÎSAP</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Human: FlpIn T-REx 293 FLAG-SAF-A ÎRGG</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <bold>Oligonucleotides</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td>Stealth RNA target sequence: SAF-A CCUGGGAAUCGTGGCGGATATAATA</td>
                  <td>ThermoFisher</td>
                  <td>Cat# HSS104917</td>
                </tr>
                <tr>
                  <td>Stealth RNA target sequence: hnRNP C GCUUUGCCUUCGUUCAGUAUGUUAA</td>
                  <td>ThermoFisher</td>
                  <td>Cat# HSS179304</td>
                </tr>
                <tr>
                  <td>Stealth RNA siRNA Negative Control, Med GC</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 12935300</td>
                </tr>
                <tr>
                  <td>Custom MyTags libraries</td>
                  <td>MYcroarray</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <bold>Recombinant DNA</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td>cDNA for SAF-A</td>
                  <td>Genome Cube</td>
                  <td>Cat# IRATp970D1041D</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-SAF-A</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-SAF-A Walker A mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-SAF-A Walker B mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-SPRY/AAA+/RGG</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-SPRY/AAA+</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-AAA+/RGG</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-AAA+/RGG Walker A mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-AAA+/RGG Walker B mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-AAA+</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-SAF-A ÎSAP</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn 3xFLAG-SAF-A ÎRGG</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn GFP-SAF-A</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn GFP-AAA+/RGG</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn GFP-AAA+/RGG Walker A mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn GFP-AAA+/RGG Walker B mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn mCherry-AAA+/RGG</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn mCherry-AAA+/RGG Walker A mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn mCherry-AAA+/RGG Walker B mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: T7-SAF-A</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: T7-SAF-A Walker A mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: T7-SAF-A Walker B mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: pET32a-AAA+</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: pET32a-AAA+ Walker A mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: pET32a-AAA+ Walker B mut.</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: pET32a-AAA+RGG</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: FlpIn LINE1 ORF2</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Plasmid: mCherry-vector</td>
                  <td>This paper</td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Human Cot-1 DNA</td>
                  <td>ThermoFisher</td>
                  <td>Cat# 15279011</td>
                </tr>
                <tr>
                  <td>pOG44</td>
                  <td>ThermoFisher</td>
                  <td>Cat# V600520</td>
                </tr>
                <tr>
                  <td>pSuper-puro vector harboring hnRNP A1 target sequence</td>
                  <td>
                    <xref rid="bib26" ref-type="bibr">Guil etÂ al., 2006</xref>
                  </td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>Fosmids</td>
                  <td>See <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref></td>
                  <td>BacPac resources</td>
                </tr>
                <tr>
                  <td>Human Chromosome 2 painting probe</td>
                  <td>Cytocell</td>
                  <td>Cat# LPP-02R-A</td>
                </tr>
                <tr>
                  <td>Human Chromosome 4 painting probe</td>
                  <td>Cytocell</td>
                  <td>Cat# LPP-04G-A</td>
                </tr>
                <tr>
                  <td>Human Chromosome 18 painting probe</td>
                  <td>MetaSystems</td>
                  <td>Cat# D-0318-050-OR</td>
                </tr>
                <tr>
                  <td>Human Chromosome 19 painting probe</td>
                  <td>MetaSystems</td>
                  <td>Cat# D-0319-050-FI</td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <bold>Software and Algorithms</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td>Woolz image processing system</td>
                  <td>
                    <xref rid="bib2" ref-type="bibr">Armit etÂ al., 2015</xref>
                  </td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="https://github.com/ma-tech/Woolz" id="intref0075">https://github.com/ma-tech/Woolz</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>MAPaint</td>
                  <td>
                    <xref rid="bib2" ref-type="bibr">Armit etÂ al., 2015</xref>
                  </td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>SymPhoTime v5.4.4</td>
                  <td>PicoQuant</td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="https://www.picoquant.com/products/category/software" id="intref0080">https://www.picoquant.com/products/category/software</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>TopHat</td>
                  <td>
                    <xref rid="bib58" ref-type="bibr">Trapnell etÂ al., 2012</xref>
                  </td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="https://ccb.jhu.edu/software/tophat/index.shtml" id="intref0085">https://ccb.jhu.edu/software/tophat/index.shtml</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>Cufflinks</td>
                  <td>
                    <xref rid="bib58" ref-type="bibr">Trapnell etÂ al., 2012</xref>
                  </td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="https://ccb.jhu.edu/software/tophat/index.shtml" id="intref0090">https://ccb.jhu.edu/software/tophat/index.shtml</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>Bowtie2</td>
                  <td>
                    <xref rid="bib37" ref-type="bibr">Langmead and Salzberg, 2012</xref>
                  </td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="http://bowtie-bio.sourceforge.net/index.shtml" id="intref0095">http://bowtie-bio.sourceforge.net/index.shtml</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>iVision</td>
                  <td>BioVisionTechnologies</td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="http://www.biovis.com/ivision.html" id="intref0100">http://www.biovis.com/ivision.html</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>Leica Application Suite Advanced Fluorescence (LAS AF) Software</td>
                  <td>Leica Microsystems</td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="http://www.leica-microsystems.com/home/" id="intref0105">http://www.leica-microsystems.com/home/</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>SMART</td>
                  <td>
                    <xref rid="bib53" ref-type="bibr">Schultz etÂ al., 1998</xref>
                  </td>
                  <td>N/A</td>
                </tr>
                <tr>
                  <td>MetaPrDOS</td>
                  <td>
                    <xref rid="bib32" ref-type="bibr">Ishida and Kinoshita, 2008</xref>
                  </td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="http://prdos.hgc.jp/cgi-bin/meta/top.cgi" id="intref0110">http://prdos.hgc.jp/cgi-bin/meta/top.cgi</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>PHYRE-2</td>
                  <td>
                    <xref rid="bib34" ref-type="bibr">Kelley etÂ al., 2015</xref>
                  </td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="http://www.sbg.bio.ic.ac.uk/%7Ephyre2/html/page.cgi?id=index" id="intref0115">http://www.sbg.bio.ic.ac.uk/â¼phyre2/html/page.cgi?id=index</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>Modeler 9v12</td>
                  <td>
                    <xref rid="bib19" ref-type="bibr">Eswar etÂ al., 2007</xref>
                  </td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="https://salilab.org/modeller/manual/" id="intref0120">https://salilab.org/modeller/manual/</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>PyMol</td>
                  <td>SchrÃ¶dinger</td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="http://www.pymol.org" id="intref0125">http://www.pymol.org</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>Pro-origami</td>
                  <td>
                    <xref rid="bib56" ref-type="bibr">Stivala etÂ al., 2011</xref>
                  </td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="http://munk.csse.unimelb.edu.au/pro-origami/" id="intref0130">http://munk.csse.unimelb.edu.au/pro-origami/</ext-link>
                  </td>
                </tr>
                <tr>
                  <td>EsPript v3</td>
                  <td>
                    <xref rid="bib25" ref-type="bibr">Gouet etÂ al., 1999</xref>
                  </td>
                  <td>
                    <ext-link ext-link-type="uri" xlink:href="http://espript.ibcp.fr/ESPript/ESPript/" id="intref0135">http://espript.ibcp.fr/ESPript/ESPript/</ext-link>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <bold>Other</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="3">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td>Prescision Coverslips</td>
                  <td>ZEISS</td>
                  <td>Cat# 474030-9000-000</td>
                </tr>
                <tr>
                  <td>FluoSpheres Carboxylate-Modified Microspheres, 0.02Â Î¼m, yellow-green fluorescent (505/515), 2% solids</td>
                  <td>ThermoFisher</td>
                  <td>Cat# F8787</td>
                </tr>
                <tr>
                  <td>HisTrap HP, 1Â Ã 5Â ml</td>
                  <td>GE Healthcare Life Sciences</td>
                  <td>Cat# 17-5248-01</td>
                </tr>
                <tr>
                  <td>CM Sepharose</td>
                  <td>Sigma-Aldrich</td>
                  <td>Cat# CCF100 Sigma</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </p>
      </sec>
      <sec id="sec4.2">
        <title>Contact for Reagent and Resource Sharing</title>
        <p>Further information and requests for reagents should be directed to and will be fulfilled by the Lead Contact, Nick Gilbert (<ext-link ext-link-type="uri" xlink:href="mailto:nick.gilbert@ed.ac.uk" id="intref0140">nick.gilbert@ed.ac.uk</ext-link>).</p>
      </sec>
      <sec id="sec4.3">
        <title>Experimental Model and Subject Details</title>
        <sec id="sec4.3.1">
          <title>Cell culture</title>
          <p>RPE1, 293T and FlpIn-T-REx-293 cells (ThermoFisher) were cultured as described previously (<xref rid="bib44" ref-type="bibr">Naughton etÂ al., 2013</xref>). GM10253AÂ hybrid cells (Coriell) were cultured in RPMI1640 supplemented with 3Â mM L-glutamine, 10% fetal calf serum, penicillin (100Â U.ml<sup>-1</sup>), streptomycin (100Â Î¼g.ml<sup>-1</sup>) and phenol red (8.1Â mg.l<sup>-1</sup>). Transcription was blocked by adding Î±-amanitin (50Â Î¼g.ml<sup>â1</sup>), flavopiridol (100Â Î¼M), actinomycin D (500Â nM) or DRB (50Â Î¼M) to cells for the times indicated. Flp-In T-REx 293 was used to establish stable cell lines for inducible expression of FLAG-tagged SAF-A and their derivatives by transfecting a modified pcDNA5/FRT Expression vector (ThermoFisher) harboring N-terminal 3Â Ã FLAG tagged SAF-A or its derivatives, and pOG44 (ThermoFisher) encoding Flp recombinase. After selection with 50Â Î¼g.ml<sup>-1</sup> hygromycin B (ThermoFisher) for 2Â weeks, the cells were treated with 1Â Î¼g.ml<sup>-1</sup> doxycycline for 24Â hr for inducing expression of proteins.</p>
        </sec>
      </sec>
      <sec id="sec4.4">
        <title>Method Details</title>
        <sec id="sec4.4.1">
          <title>Plasmids</title>
          <p>cDNA for human SAF-A was obtained from Genome Cube (IRATp970D1041D). Truncation and point mutations of SAF-A were constructed by a standard PCR cloning strategy and inserted into the corresponding vectors with indicated tags. All plasmids were verified by DNA sequencing. siRNA resistant SAF-A was constructed by introducing silent mutations into the nucleotide sequence (2113-2124Â bp) 5â²-CCTGGGAATCGT-3â² as follows: 5â²- CCaGGaAAcCGa â3â². The SAF-A cDNA and derivatives were inserted into a modified pcDNA5/FRT Expression vector (ThermoFisher) with an N-terminal 3Â Ã FLAG tag for transient expression in 293T and RPE1 cells and for stable expression in FlpIn T-REx 293 cells. For recombinant expression in <italic>E.Â coli</italic>, SAF-A derivatives were cloned into a pET32a vector with an N-terminal 6Â Ã His tag. For PLA, T7 SAF-A derivatives were cloned into a modified pCGN vector where the HA tag was replaced by a T7 tag.</p>
        </sec>
        <sec id="sec4.4.2">
          <title>RNA interference</title>
          <p>For siRNA treatment, cells (10%â20% confluent) were transfected with 10Â nM Stealth RNA (ThermoFisher) using Lipofectamine RNAi MAX (ThermoFisher) for the time indicated. Stealth RNA sequences and the identification numbers are CCUGGGAAUCGTGGCGGATATAATA HSS104917 for SAF-A and GCUUUGCCUUCGUUCAGUAUGUUAA HSS179304 for hnRNP C. The control RNA is Stealth RNAi siRNA Negative Control, Med GC (ThermoFisher).</p>
          <p>For shRNA treatment, RPE1 cells (80% confluent) were transfected with pSuper-puro vector harboring hnRNP A1 target sequence using Lipofectamine 2000 (ThermoFisher). After 48Â hr selection with 3Â Î¼g.ml<sup>-1</sup> puromycin, DNA-FISH and western blotting were performed.</p>
        </sec>
        <sec id="sec4.4.3">
          <title>SAF-A extraction</title>
          <p>To analyze Triton X-100 soluble/insoluble SAF-A, cells were treated with CSK buffer containing 100Â mM NaCl, 0.1% Triton X-100, 300Â mM Sucrose, 1Â mM MgCl<sub>2</sub>, 1Â mM EGTA, 10Â mM PIPES (pH 6.8), and 100Â Î¼M PMSF (phenylmethylsulfonyl fluoride) on ice for 10Â min, followed by immuno-staining or divided into the supernatant and pellet fractions by centrifugation, at 5000Â rpm, 4Â°C for 5Â min, for western blotting. To analyze DNase or RNase A/T1 extraction of SAF-A, cells were treated with CSK buffer containing 100 units.mL<sup>-1</sup> DNase I (ThermoFisher) and 2.5Â mM CaCl<sub>2</sub> or 0.5/20 units.ml<sup>-1</sup> RNase A/T1 (Ambion) for 30Â min at R.T. and were divided into the supernatant and pellet by centrifugation, at 5000Â rpm, 4Â°C for 5Â min.</p>
        </sec>
        <sec id="sec4.4.4">
          <title>Oligomerization assay</title>
          <p>1Â Ã 10<sup>6</sup> 293T cells were exposed to disuccinimidyl suberate (DSS; 1Â mM, 0.3Â mM, 0.1Â mM), 1,8-bismaleimido-diethyleneglycol (BM(PEG)2; 1Â mM, 0.3Â mM, 0.1Â mM) or N-Î³-maleimidobutyryl-oxysuccinimide ester (GMBS; 1Â mM, 0.3Â mM, 0.1Â mM) crosslinkingÂ for 5Â min at R.T. in PBS or permeabilised with 100Â Î¼L of reaction buffer including 125Â mM NaCl, 50Â mM Tris pH 7.0 (for BM(PEG)2) or 50Â mM PIPES pH7.0 (for DSS or GMBS), 5Â mM MgCl<sub>2</sub> and 0.1% Triton X-100 at 37Â°C for 10Â min before crosslinking. After quenching DSS with 20Â mM Tris pH 7.0, BM(PEG)2 with 20Â mM L-cysteine (Sigma-Aldrich) or GMBS with 20Â mM Tris pH 7.0 and 20Â mM L-cysteine, cells were processed for western blotting. 0.3Â mM cross-linker was used for routine experiments while 1Â mM was used for SAF-A IPs (<xref rid="fig4" ref-type="fig">Figures 4</xref>C and 4E).</p>
          <p>For <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>B right, reaction buffer was supplemented with 5Â mM ATP or ATPÎ³S. For <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>D, after pre-treatment with 3Â Î¼g.ml<sup>-1</sup> PureLink RNaseA (ThermoFisher) in reaction buffer at 37Â°C for 10Â min, 293T cell lysates were incubated in the presence or absence of 30Â Î¼g.ml<sup>-1</sup> total RNA from 293T cells and 5 units.ml<sup>-1</sup> Apyrase (NEB) at 37Â°C for 10Â min, following by crosslinking. After RNaseA treatment reaction buffer was supplemented with RNasin Plus RNase Inhibitor (Promega) 1000 units.ml<sup>-1</sup>, 1Â mM DTT and 5Â mM CaCl<sub>2</sub>.</p>
        </sec>
        <sec id="sec4.4.5">
          <title>Protein gels and western blotting</title>
          <p>Cells were suspended in NuPAGE LDS sample buffer (ThermoFisher) with 10Â mM DTT, incubated at 100Â°C for 5Â min and sonicated briefly. For SAF-A oligomer blots, protein samples were resolved on 5 or 8% bis-tris gels or 7% tris-acetate gels (ThermoFisher) and transferred to Immobilon-P PVDF 0.45Â Î¼m membrane (Merck Millipore) by wet transfer. Membranes were probed with antibodies using standard techniques and detected by enhanced chemiluminescence.</p>
        </sec>
        <sec id="sec4.4.6">
          <title>Immunoprecipitation and Native PAGE</title>
          <p>FLAG-tagged SAF-A expressed in 293T cells was cross-linked with 1Â mM 1,8-bismaleimido-diethyleneglycol (BM(PEG)2) or 1Â mM dithio-bis-maleimidoethane (DTME), was extracted by sonication (10Â Ã 30Â s at amplitude 2Â Î¼m), immuno-purified using anti-FLAG M2 agarose beads (Sigma-Aldrich) and eluted with 100Â Î¼g.ml<sup>-1</sup> 3Â Ã FLAG peptide (Sigma-Aldrich) suspended in 50Â mM NaCl, 50Â mM Tris pH 7.0, 5Â mM MgCl<sub>2</sub> and 0.1% Triton X-100. For <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>E, immunoprecipitants were incubated in the presence or absence of 10Â mM DTT to reverse crosslinks, 0.5/20 units.ml<sup>-1</sup> RNase A/T1, 5 units.ml<sup>-1</sup> Apyrase, 1Â mM ATP or 1mM ATPÎ³S for 30Â min at 37Â°C. A 4%â16% NativePAGE bis-tris gel (ThermoFisher) was used for native protein fractionation, according to the manufacturerâs instructions. In <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>C, 5-ethynyl uridine was conjugated to 0.2Â mM biotin azide (PEG4 carboxamide-6-azidohexanyl biotin; ThermoFisher) using click chemistry, transferred to PVDF membrane, followed by incubation with ExtrAvidinâPeroxidase (Sigma-Aldrich) and detected with SuperSignal West Femto (ThermoFisher).</p>
        </sec>
        <sec id="sec4.4.7">
          <title>Purification of recombinant proteins</title>
          <p>To obtain SAF-A proteins, E.coli BL21 (DE3) cells transformed with a pET32a vector encoding SAF-A cDNA were grown in 2Â Ã YT medium (16 g.ml<sup>-1</sup> Tryptone, 10 g.ml<sup>-1</sup> Yeast extract, 5 g.ml<sup>-1</sup> NaCl) supplemented with 20Â Î¼g.ml<sup>-1</sup> ampicillin and 20Â Î¼g.ml<sup>-1</sup> chloramphenicol. Protein expression was induced overnight at 18Â°C with 1Â mM IPTG after OD600 reached 0.6. Cells were lysed in buffer containing 50Â mM Tris-HCl (pH 8.0), 500Â mM NaCl, 60Â mM imidazole, 10% glycerol, 0.1% Triton X-100 and 1Â mM DTT. The SAF-A proteins were affinity-purified by HisTrap HP (GE Healthcare Life Sciences), dialysed into 150Â mM NaCl, 30Â mM imidazole (pH 7.0) and 1Â mM DTT overnight at 4Â°C and were further purified by CM-Sepharose cation exchange chromatography (Sigma-Aldrich) and eluted using a 150 to 500Â mM NaCl gradient in dialysis buffer.</p>
        </sec>
        <sec id="sec4.4.8">
          <title>ATPase activity assay</title>
          <p>An ATPase activity assay was performed with 3.0Â Î¼m SAF-A protein in reaction buffer (50Â mM TrisâHCl (pH 7.5), 125Â mM NaCl, 10Â mM MgCl<sub>2</sub>, 5Â mM DTT, 1Â mM ATP or 1Â mM GTP) in a final volume of 50Â Î¼L for 30Â min at 37Â°C. The 10Â Î¼L reaction was quenched with 90Â Î¼L of BIOMOL Green (Enzo Life Science) and free phosphate was detected by absorbance at 620Â nm using a Tecan M200Pro. A phosphate standard curve was used to estimate the amount of phosphate released during ATP hydrolysis. Error bars denote standard deviations from three independent samples.</p>
        </sec>
        <sec id="sec4.4.9">
          <title>Fluorescence studies by luminescence spectroscopy</title>
          <p>Fluorescence experiments were performed at 37Â°C using a LS 50 PerkinElmer luminescence spectrometer. Reactions comprised 4Â Î¼m SAF-A in 50Â mM TrisâHCl (pH 7.5), 125Â mM NaCl, 10Â mM MgCl<sub>2</sub>, 5Â mM DTT. Spectra for SAF-A AAA+ fragments were obtained with 290Â nm excitation wavelength and fluorescence changes calculated at 360Â nm. All fluorescence measurements were performed in duplicate.</p>
        </sec>
        <sec id="sec4.4.10">
          <title>Proximity ligation assay (PLA)</title>
          <p>FlpIn T-REx 293 cells carrying an inducible copy of wild-type or mutant SAF-A were transfected with stealth RNAi to knock down endogenous SAF-A using RNAi MAX (ThermoFisher) for 24Â hr. Cells were then transfected with plasmids encoding T7-tagged SAF-A or point mutants with Lipofectamine 3000 (ThermoFisher) and the expression of FLAG-tagged-SAF-A was induced with doxycycline at the same time. After 24Â hr, PLA was performed according to the manufacturerâs instructions using Duolink inÂ situ (Sigma-Aldrich).</p>
        </sec>
        <sec id="sec4.4.11">
          <title>[5-3H]uridine incorporation</title>
          <p>Nascent transcription was measured as described (<xref rid="bib44" ref-type="bibr">Naughton etÂ al., 2013</xref>).</p>
        </sec>
        <sec id="sec4.4.12">
          <title>5-EU incorporation</title>
          <p>Cells were treated with 1Â mM 5-ethynyl uridine (Base Click) and 1Â mM thymidine (Sigma-Aldrich) for the indicated time. In FigureÂ S6C, cells were pretreated with 50Â ng.ml<sup>-1</sup> actinomycin D. Click reaction was performed with Click-iT EdU Alexa Fluor 647 Imaging Kit or Click-iT Nascent RNA Capture Kit, according to the manufacturerâs instructions (ThermoFisher).</p>
        </sec>
        <sec id="sec4.4.13">
          <title>4-thiouridine incorporation and quantification of nucleosides</title>
          <p>After 30Â min incubation with 0.5Â mM 4-thiouridine cells were rinsed with PBS and lysed in DNA lysis buffer (100Â mM EDTA, 20Â mM Tris pH 7.5, 50Â mM NaCl 0.5% SDS and 300Â Î¼g.ml<sup>-1</sup> protease K). The cell lysate was incubate at 37Â°C for 30Â min and precipitated in 2 volumes of ethanol. The precipitate was suspended in 70% ethanol overnight and resuspended in 50Â Î¼L of combined DNA and RNA lysis buffer (1Â Ã DNaseI digestion buffer (NEB) with 1Â mM ZnSO4). The nucleic acid was digested with 1Â Î¼L Dnase I (NEB) and 2Â Î¼L (1Â mg.ml<sup>-1</sup>) nuclease P1 for 24Â hr at 37Â°C. After this the sample was denatured by heat (95Â°C for 5Â min) and rapidly cooled on ice. 2 volumes of 30Â mM Na acetate pH 5.2, (1Â mM ZnSO4) was added and the sample was digested with fresh DNaseI (1Â Î¼l) and Nuclease P1 (2Â Î¼l) for a further 24Â hr at 37Â°C. 50Â Î¼L of lysate was separated by reverse phase HPLC.</p>
          <p>HPLC was carried out on a Dionex Ultimate 3000 HPLC system equipped with Chromeleon software, a column chiller (8Â°C), 5Â Î¼m APEX ODS C18 column, 50Â mM ammonium phosphate (monobasic) mobile phase (1Â ml.min<sup>-1</sup>), and a UV absorbance detector capable of collecting UV absorbance at 5 wavelengths simultaneously. Nucleotides were detected at their peak absorbances: thymidine 5â²monophosphate (in DNA) at 268Â nm (retention time 22.5Â min), guanosine monophosphate (in RNA) at 254Â nm (retention time 11.5Â min), and 4-thiouridine monophosphate (in RNA) at 323Â nm (retention time 14.7Â min). Nucleotide quantities were measured by the areas under each peak at the respective peak UV absorbances.</p>
        </sec>
        <sec id="sec4.4.14">
          <title>RNA Sequencing and analysis</title>
          <p>Total RNA from cells transfected with siRNA for the time indicated were prepared with RNeasy Mini kit (QIAGEN) and treated with ribo-Zero kit (illumina) to remove ribosomal RNA. RNA-seq libraries were prepared with a NEBNextÂ® Ultra RNA Library Prep Kit for Illumina (NEB), according to manufacturerâs instructions, and were quantified using a BioAnalyzer 2100 with a High Sensitivity DNA Kit (Agilent). RNA-seq Libraries were analyzed by Edinburgh Genomics at the University of Edinburgh, UK, for quality control and sequencing (HiSeq2500, 50 base single-end reads). RNA-seq data were processed using a standard TopHat and Cufflinks methodology (<xref rid="bib58" ref-type="bibr">Trapnell etÂ al., 2012</xref>). Single end reads were aligned using Tophat 2.0.10 and Bowtie 2.1.0 using a human hg19 bowtie2 index. Aligned reads were processed using Cufflinks 2.2.1 with a human hg19 reference annotation and differential gene expression calculated between control and knockdown samples with Cuffdiff using a 0.0005Â p value cut off.</p>
        </sec>
        <sec id="sec4.4.15">
          <title>Three-dimensional RNA/DNA fluorescence inÂ situ hybridization</title>
          <p>3D RNA/DNA FISH was performed as described (<xref rid="bib43" ref-type="bibr">Naughton etÂ al., 2010</xref>). Fosmid probes (BacPac resources), human LINE1 cDNA and human C0t1 DNA (ThermoFisher) were labeled in digoxigenin-11-UTP or biotin-16-dUTP. Custom MyTags libraries for Oligo-DNA-FISH were synthesized to cover 20 kb of genomic sequence positioned every 1 Mb across a 10 Mb region of the genome (MYcroarray). Gene rich library probes labeled with ATTO 488 cover chr11: 760000 â 10980000. Gene poor library probes labeled with ATTO 550 cover chr11: 20000000 â 29200000. Each 5Â Î¼m probe was hybridized as for DNA-FISH. Chromosome Painting was performed using a chromosome 2 painting probe labeled with Texas Red and a chromosome 4 painting probe labeled with FITC (Cytocell) or a chromosome 18 or chromosome 19 paint (MetaSystem) directly labeled with Spectrum Orange or FITC, respectively.</p>
        </sec>
        <sec id="sec4.4.16">
          <title>Image capture and analysis</title>
          <p>Image capture and analysis was performed as described (<xref rid="bib44" ref-type="bibr">Naughton etÂ al., 2013</xref>) and image color balance was adjusted to improve data visualization in the manuscript.</p>
        </sec>
        <sec id="sec4.4.17">
          <title>STED microscopy</title>
          <p>Super-resolution images were acquired using a STED microscope. Flp-In T-REx 293 cells depleted of endogenous SAF-A (48 h) and then doxycycline induced for 24Â hr to express wild-type or mutant SAF-A were prepared on high precision cover-glass (Zeiss, Germany). STED images were acquired on a Leica SP5 SMD g-STED microscope (Leica Microsystems, Germany) using a 100Â Ã objective lens (HC PL APO 100Â Ã /1.40 Oil STED White) with immersion oil (Leica Type F, refractive index 1.5180). A confocal image was taken using a 488Â nm laser for FLAG-SAF-A and 647Â nm laser for DRAQ7 stained DNA. The STED image was taken using 488Â nm for excitation from a white light, super continuum laser and a pulsed 592Â nm laser for depletion. Detection was with a HyD detector with a time gate of 0.5-6Â ns. STED image processing and analysis were carried out using the STED module of the LAS AF (Leica Application Suite Advanced Fluorescence). STED resolution was assessed by imaging 20Â nm fluorescent beads (ThermoFisher). To measure image granularity nuclei were segmented on DRAQ7 to exclude background and nucleoli using an iVision script. The resulting mask was used to isolate SAF-A image data, background signal was removed and granules were segmented based on intensity script and quantified for each nucleus.</p>
        </sec>
        <sec id="sec4.4.18">
          <title>Fluorescence lifetime imaging microscopy (FLIM) data acquisition</title>
          <p>FÃ¶rster Resonance Energy Transfer (FRET) is a process whereby the transfer of energy occurs from an excited state fluorophore (donor) to a second chromophore (acceptor) in close proximity and is used to detect molecular interactions inÂ vivo where two molecules are less than 10Â nm apart. In FLIM-FRET microscopy, fluorescence lifetime is measured as a quantitative readout of FRET, with interactions causing a decrease in the fluorescence lifetime of the donor molecules. We performed FLIM-FRET experiments with 293T cells transiently transfected with either GFP-AAA+/RGG SAF-A fragment (donor alone) or GFP-AAA+/RGG and mCherry-AAA+/RGG together to investigate the oligomerization of SAF-A in different conditions. To deplete endogenous SAF-A, 293T cells were transfected with stealth RNA using RNAiMAX for 24Â hr and transfected with GFP-AAA/+RGG and mCherry-AAA+/RGG wild-type or point mutants with Lipofectamine 3000 for 24Â hr. Acquisition was performed on a Leica SP5 SMD (Single Molecule Detection) confocal laser-scanning microscope using a 63Â Ã 1.4NA HCX PL Apo oil immersion objective lens. The GFP donor fluorophore was excited using a tunable white light laser operating at 488Â nm and 40 MHz pulse rate. Emission was detected with an external single photon avalanche diode (MicroPhoton Devices) and photon arrival time relative to the laser pulse was determined using a PicoHarp 300 time-correlated single photon counting (TCSPC) module. FLIM measurements were integrated for 120Â s with a 512Â Ã 512 pixel format at a maximum photon count rate of 105 counts per second and subsequently binned to a 256Â Ã 256 pixel format to maximize photon counts per pixel for accurate data fitting.</p>
        </sec>
        <sec id="sec4.4.19">
          <title>FLIM-FRET analysis</title>
          <p>FLIM analysis was carried out using SymPhoTime v5.4.4 (PicoQuant). The measured fluorescence decay was fitted to a bi-exponential decay model using the maximum-likelihood estimation method. Fluorescence lifetime values were determined by pixel-by-pixel fitting, which was guided by an initial global decay fit. Reported fluorescence lifetimes are an amplitude-weighted average of the two decay components, Ñ<sub>amp</sub>
<italic>=</italic> (A<sub>1</sub>Ñ<sub>1</sub>Â + A<sub>2</sub>Ñ<sub>2</sub>) / (A<sub>1</sub>Â + A<sub>2</sub>) (where A<sub>1</sub> and A<sub>2</sub> are the amplitudes of the decay components and Ñ<sub>1</sub> and Ñ<sub>2</sub> are the fluorescence lifetimes) and were only calculated for pixels with greater than 300 photon counts. FRET efficiency, E<sub>FRET</sub>Â = 1 â Ñ<sub>DA</sub>/Ñ<sub>D</sub>, where Ï<sub>DA</sub> is the lifetime of the donor (GFP) in the presence of the acceptor (mCherry) and Ñ<sub>D</sub> is the single pixel median amplitude-weighted fluorescence lifetime reported for the GFP donor-only sample, calculated per pixel from the GFP-mCherry samples. Image maps representing FRET efficiency per pixel were constructed in R using the spatstat package.</p>
        </sec>
        <sec id="sec4.4.20">
          <title>Protein sequence analysis and domain identification</title>
          <p>The domain composition of SAF-A was initially observed using SMART (<xref rid="bib53" ref-type="bibr">Schultz etÂ al., 1998</xref>) and then the most likely domain sequence lengths extended on the basis of homology searches of the Protein Data Bank (PDB) taking into consideration additional conserved secondary structure elements for the SAP (PDB ID: <ext-link ext-link-type="uri" xlink:href="pdb:1ZRJ" id="intref0145">1ZRJ</ext-link>), SPRY (PDB ID: <ext-link ext-link-type="uri" xlink:href="pdb:3TOJ" id="intref0150">3TOJ</ext-link>) and AAA (3ZVL) domains, respectively. The C-terminal RNA binding region was annotated on the basis of functional studies (<xref rid="bib35" ref-type="bibr">Kiledjian and Dreyfuss, 1992</xref>). The disordered regions were predicted using MetaPrDOS (<xref rid="bib32" ref-type="bibr">Ishida and Kinoshita, 2008</xref>) by integrating results from 5 disorder prediction methods (see <xref rid="figs3" ref-type="fig">FigureÂ S3</xref>A).</p>
        </sec>
        <sec id="sec4.4.21">
          <title>Fold recognition and 3D homology modeling of SAF-A AAA domain</title>
          <p>The SAF-A isoform 2 AAA domain sequence (aa 469-653) was analyzed using PHYRE-2 (<xref rid="bib34" ref-type="bibr">Kelley etÂ al., 2015</xref>) to assess fold compatibility. All returned top hits were AAA superfamily related with 100% confidence. The AAA domain from the crystal structure of the mammalian polynucleotide kinase 3â² phosphatase PDB ID: <ext-link ext-link-type="uri" xlink:href="pdb:3ZVL" id="intref0155">3ZVL</ext-link> chain A (1.65Â Ã) was selected as a template for modeling the SAF-A AAA domain based upon an HHPred search of the PDB70 database. The HMM-HMM target-template alignment was used as input for modeling after manual checking of alignment, secondary structure equivalence, gap positioning and undertaking minor editing. A PsiPred secondary structure prediction identified an additional predicted Î± -helix (aa 512-521) and an extended Î±-helix (aa 533-554) when compared with the template located after the canonical Î² strand 2; these additional predicted secondary structure features were restrained during the model building process. A total of 100 models were built using Modeler 9v12 (<xref rid="bib19" ref-type="bibr">Eswar etÂ al., 2007</xref>) and the model with the lowest âDOPEâ energy (<xref rid="bib55" ref-type="bibr">Shen and Sali, 2006</xref>) was selected as the representative model, and assessed for valid stereochemistry (Ramachandran plot: 98.9% of residues in favored and allowed regions) and packing quality (average Z-score â1.04). PyMol (<ext-link ext-link-type="uri" xlink:href="http://www.pymol.org" id="intref0160">http://www.pymol.org</ext-link>) was used for 3D visualization, analysis and figure preparation. Pro-origami was used to create the 2-D cartoon topology schematic (<xref rid="bib56" ref-type="bibr">Stivala etÂ al., 2011</xref>). The target-template alignment was generated and annotated using EsPript v3 (<xref rid="bib25" ref-type="bibr">Gouet etÂ al., 1999</xref>).</p>
        </sec>
      </sec>
      <sec id="sec4.5">
        <title>Quantification and Statistical Analysis</title>
        <p>The statistical significance of compaction was tested using a nonparametric MannâWhitney U (Wilcoxon) test (using R programming). pÂ &lt; 0.05 was taken as statistically significant. For oligo probe DNA-FISH analysis, the Woolz image processing system, initially developed for the eMouseAtlas program (<xref rid="bib2" ref-type="bibr">Armit etÂ al., 2015</xref>), was used to analyze the distribution of 3D DNA-FISH spot images. MAPaint, a Woolz based interactive 3D segmentation tool, was used to delineate spot domains. From these domains convex hulls and their volumes were then computed. The open source Woolz image processing system is freely available from <ext-link ext-link-type="uri" xlink:href="https://github.com/ma-tech/Woolz" id="intref0165">https://github.com/ma-tech/Woolz</ext-link>. For analyzing DAPI texture cells were grown overnight on slides, stained with DAPI and mounted. 12 bit images were collected using a 405Â nm laser on a SP5 confocal microscope (Leica) using a 100Â Ã objective and were segmented to exclude background and nucleoli using a custom iVision (BioVis) script. Segmented nuclei were sub-sampled 100Â Ã each with an 8Â Ã 8, 12Â Ã 12, 16Â Ã 16, 20Â Ã 20, 24Â Ã 24 and 28Â Ã 28 window (i.e., 600 measurements per nucleus using an iVision script). Sub-sampled images were imported into R and visualized using the spatstat package. To quantify texture images were transformed to a gray level co-occurrence matrix (GLCM) using the radiomics package and second order matrix statistics were calculated.</p>
      </sec>
      <sec id="sec4.6">
        <title>Data and Software Availability</title>
        <p>The accession number for RNA sequencing reported in this paper is NCBI GEO: <ext-link ext-link-type="uri" xlink:href="ncbi-geo:GSE98541" id="intref0170">GSE98541</ext-link>.</p>
      </sec>
    </sec>
    <sec id="sec5">
      <title>Author Contributions</title>
      <p>R.-S.N., L.B., C.N., A.R.D., M.A., B.R., P.C.B., S.K.M., and N.G. performed laboratory experiments. D.C.S., A.B., B.H., R.S.S., and B.R. undertook data analysis. R.-S.N., L.B., R.R.D., S.K.M., and N.G. designed the study. R.-S.N., L.B., and N.G. wrote the manuscript with contributions from all the authors.</p>
    </sec>
  </body>
  <back>
    <ref-list id="cebib0010">
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal" id="sref1">
          <person-group person-group-type="author">
            <name>
              <surname>Aravind</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Koonin</surname>
              <given-names>E.V.</given-names>
            </name>
          </person-group>
          <article-title>SAP - a putative DNA-binding motif involved in chromosomal organization</article-title>
          <source>Trends Biochem. Sci.</source>
          <volume>25</volume>
          <year>2000</year>
          <fpage>112</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="pmid">10694879</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal" id="sref2">
          <person-group person-group-type="author">
            <name>
              <surname>Armit</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>eMouseAtlas informatics: embryo atlas and gene expression database</article-title>
          <source>Mamm. Genome</source>
          <volume>26</volume>
          <year>2015</year>
          <fpage>431</fpage>
          <lpage>440</lpage>
          <pub-id pub-id-type="pmid">26296321</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal" id="sref3">
          <person-group person-group-type="author">
            <name>
              <surname>Belmont</surname>
              <given-names>A.S.</given-names>
            </name>
          </person-group>
          <article-title>Large-scale chromatin organization: the good, the surprising, and the still perplexing</article-title>
          <source>Curr. Opin. Cell Biol.</source>
          <volume>26</volume>
          <year>2014</year>
          <fpage>69</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">24529248</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal" id="sref4">
          <person-group person-group-type="author">
            <name>
              <surname>Belmont</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Braunfeld</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Sedat</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Agard</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Large-scale chromatin structural domains within mitotic and interphase chromosomes inÂ vivo and inÂ vitro</article-title>
          <source>Chromosoma</source>
          <volume>98</volume>
          <year>1989</year>
          <fpage>129</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">2476279</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal" id="sref5">
          <person-group person-group-type="author">
            <name>
              <surname>Berezney</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Coffey</surname>
              <given-names>D.S.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a nuclear protein matrix</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>60</volume>
          <year>1974</year>
          <fpage>1410</fpage>
          <lpage>1417</lpage>
          <pub-id pub-id-type="pmid">4214419</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal" id="sref6">
          <person-group person-group-type="author">
            <name>
              <surname>Boettiger</surname>
              <given-names>A.N.</given-names>
            </name>
            <name>
              <surname>Bintu</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Moffitt</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Beliveau</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Fudenberg</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Imakaev</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mirny</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>C.-T.</given-names>
            </name>
            <name>
              <surname>Zhuang</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Super-resolution imaging reveals distinct chromatin folding for different epigenetic states</article-title>
          <source>Nature</source>
          <volume>529</volume>
          <year>2016</year>
          <fpage>418</fpage>
          <lpage>422</lpage>
          <pub-id pub-id-type="pmid">26760202</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal" id="sref7">
          <person-group person-group-type="author">
            <name>
              <surname>Brackley</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Marenduzzo</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Simulated binding of transcription factors to active and inactive regions folds human chromosomes into loops, rosettes and topological domains</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>44</volume>
          <year>2016</year>
          <fpage>3503</fpage>
          <lpage>3512</lpage>
          <pub-id pub-id-type="pmid">27060145</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal" id="sref8">
          <person-group person-group-type="author">
            <name>
              <surname>Britton</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dernoncourt</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Delteil</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Froment</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Schiltz</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Salles</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Frit</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Calsou</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>DNA damage triggers SAF-A and RNA biogenesis factors exclusion from chromatin coupled to R-loops removal</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>42</volume>
          <year>2014</year>
          <fpage>9047</fpage>
          <lpage>9062</lpage>
          <pub-id pub-id-type="pmid">25030905</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal" id="sref9">
          <person-group person-group-type="author">
            <name>
              <surname>Caudron-Herger</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Rippe</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Nuclear architecture by RNA</article-title>
          <source>Curr. Opin. Genet. Dev.</source>
          <volume>22</volume>
          <year>2012</year>
          <fpage>179</fpage>
          <lpage>187</lpage>
          <pub-id pub-id-type="pmid">22281031</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal" id="sref10">
          <person-group person-group-type="author">
            <name>
              <surname>Chubb</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bickmore</surname>
              <given-names>W.A.</given-names>
            </name>
          </person-group>
          <article-title>Chromatin motion is constrained by association with nuclear compartments in human cells</article-title>
          <source>Curr. Biol.</source>
          <volume>12</volume>
          <year>2002</year>
          <fpage>439</fpage>
          <lpage>445</lpage>
          <pub-id pub-id-type="pmid">11909528</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal" id="sref11">
          <person-group person-group-type="author">
            <name>
              <surname>Croft</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Bridger</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Teague</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bickmore</surname>
              <given-names>W.A.</given-names>
            </name>
          </person-group>
          <article-title>Differences in the localization and morphology of chromosomes in the human nucleus</article-title>
          <source>J.Â Cell Biol.</source>
          <volume>145</volume>
          <year>1999</year>
          <fpage>1119</fpage>
          <lpage>1131</lpage>
          <pub-id pub-id-type="pmid">10366586</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal" id="sref12">
          <person-group person-group-type="author">
            <collab>Deciphering Developmental Disorders Study</collab>
          </person-group>
          <article-title>Large-scale discovery of novel genetic causes of developmental disorders</article-title>
          <source>Nature</source>
          <volume>519</volume>
          <year>2015</year>
          <fpage>223</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">25533962</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal" id="sref13">
          <person-group person-group-type="author">
            <name>
              <surname>Douglas</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Morrice</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Britton</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Trinkle-Mulcahy</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lees-Miller</surname>
              <given-names>S.P.</given-names>
            </name>
          </person-group>
          <article-title>Phosphorylation of SAF-A/hnRNP-U serine 59 by Polo-like kinase 1 is required for mitosis</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>35</volume>
          <year>2015</year>
          <fpage>2699</fpage>
          <lpage>2713</lpage>
          <pub-id pub-id-type="pmid">25986610</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal" id="sref14">
          <person-group person-group-type="author">
            <name>
              <surname>Duderstadt</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Mott</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Crisona</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Chuang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Origin remodeling and opening in bacteria rely on distinct assembly states of the DnaA initiator</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>285</volume>
          <year>2010</year>
          <fpage>28229</fpage>
          <lpage>28239</lpage>
          <pub-id pub-id-type="pmid">20595381</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal" id="sref15">
          <person-group person-group-type="author">
            <name>
              <surname>Duderstadt</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Chuang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>DNA stretching by bacterial initiators promotes replication origin opening</article-title>
          <source>Nature</source>
          <volume>478</volume>
          <year>2011</year>
          <fpage>209</fpage>
          <lpage>213</lpage>
          <pub-id pub-id-type="pmid">21964332</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal" id="sref16">
          <person-group person-group-type="author">
            <name>
              <surname>Ebisuya</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nakajima</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Ripples from neighbouring transcription</article-title>
          <source>Nat. Cell Biol.</source>
          <volume>10</volume>
          <year>2008</year>
          <fpage>1106</fpage>
          <lpage>1113</lpage>
          <pub-id pub-id-type="pmid">19160492</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal" id="sref17">
          <person-group person-group-type="author">
            <name>
              <surname>Erzberger</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Evolutionary relationships and structural mechanisms of AAA+ proteins</article-title>
          <source>Annu. Rev. Biophys. Biomol. Struct.</source>
          <volume>35</volume>
          <year>2006</year>
          <fpage>93</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="pmid">16689629</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal" id="sref18">
          <person-group person-group-type="author">
            <name>
              <surname>Erzberger</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Mott</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Structural basis for ATP-dependent DnaA assembly and replication-origin remodeling</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>13</volume>
          <year>2006</year>
          <fpage>676</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="pmid">16829961</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal" id="sref19">
          <person-group person-group-type="author">
            <name>
              <surname>Eswar</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Marti-Renom</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Madhusudhan</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Eramian</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>M.-Y.</given-names>
            </name>
            <name>
              <surname>Pieper</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Sali</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Comparative protein structure modeling using MODELLER</article-title>
          <source>Curr. Protoc. Protein Sci.</source>
          <volume>Chapter 2</volume>
          <year>2007</year>
          <comment>Unit 2.9</comment>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal" id="sref20">
          <person-group person-group-type="author">
            <name>
              <surname>Fey</surname>
              <given-names>E.G.</given-names>
            </name>
            <name>
              <surname>Ornelles</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Penman</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Association of RNA with the cytoskeleton and the nuclear matrix</article-title>
          <source>J.Â Cell Sci. Suppl.</source>
          <volume>5</volume>
          <year>1986</year>
          <fpage>99</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="pmid">3477558</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal" id="sref21">
          <person-group person-group-type="author">
            <name>
              <surname>Ghanbarian</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Hurst</surname>
              <given-names>L.D.</given-names>
            </name>
          </person-group>
          <article-title>Neighboring genes show correlated evolution in gene expression</article-title>
          <source>Mol. Biol. Evol.</source>
          <volume>32</volume>
          <year>2015</year>
          <fpage>1748</fpage>
          <lpage>1766</lpage>
          <pub-id pub-id-type="pmid">25743543</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal" id="sref22">
          <person-group person-group-type="author">
            <name>
              <surname>Gilbert</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fiegler</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Woodfine</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>N.P.</given-names>
            </name>
            <name>
              <surname>Bickmore</surname>
              <given-names>W.A.</given-names>
            </name>
          </person-group>
          <article-title>Chromatin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers</article-title>
          <source>Cell</source>
          <volume>118</volume>
          <year>2004</year>
          <fpage>555</fpage>
          <lpage>566</lpage>
          <pub-id pub-id-type="pmid">15339661</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal" id="sref23">
          <person-group person-group-type="author">
            <name>
              <surname>Goetze</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mateos-Langerak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gierman</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>de Leeuw</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Giromus</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Indemans</surname>
              <given-names>M.H.G.</given-names>
            </name>
            <name>
              <surname>Koster</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ondrej</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Versteeg</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>van Driel</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>The three-dimensional structure of human interphase chromosomes is related to the transcriptome map</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>27</volume>
          <year>2007</year>
          <fpage>4475</fpage>
          <lpage>4487</lpage>
          <pub-id pub-id-type="pmid">17420274</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal" id="sref24">
          <person-group person-group-type="author">
            <name>
              <surname>GÃ¶hring</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Schwab</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Nicotera</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Leist</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fackelmayer</surname>
              <given-names>F.O.</given-names>
            </name>
          </person-group>
          <article-title>The novel SAR-binding domain of scaffold attachment factor A (SAF-A) is a target in apoptotic nuclear breakdown</article-title>
          <source>EMBO J.</source>
          <volume>16</volume>
          <year>1997</year>
          <fpage>7361</fpage>
          <lpage>7371</lpage>
          <pub-id pub-id-type="pmid">9405365</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal" id="sref25">
          <person-group person-group-type="author">
            <name>
              <surname>Gouet</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Courcelle</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Stuart</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>MÃ©toz</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>ESPript: analysis of multiple sequence alignments in PostScript</article-title>
          <source>Bioinformatics</source>
          <volume>15</volume>
          <year>1999</year>
          <fpage>305</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="pmid">10320398</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal" id="sref26">
          <person-group person-group-type="author">
            <name>
              <surname>Guil</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>CÃ¡ceres</surname>
              <given-names>J.F.</given-names>
            </name>
          </person-group>
          <article-title>hnRNP A1 relocalization to the stress granules reflects a role in the stress response</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>26</volume>
          <year>2006</year>
          <fpage>5744</fpage>
          <lpage>5758</lpage>
          <pub-id pub-id-type="pmid">16847328</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal" id="sref27">
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>L.L.</given-names>
            </name>
            <name>
              <surname>Lawrence</surname>
              <given-names>J.B.</given-names>
            </name>
          </person-group>
          <article-title>RNA as a fundamental component of interphase chromosomes: could repeats prove key?</article-title>
          <source>Curr. Opin. Genet. Dev.</source>
          <volume>37</volume>
          <year>2016</year>
          <fpage>137</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">27218204</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal" id="sref28">
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>L.L.</given-names>
            </name>
            <name>
              <surname>Carone</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Kolpa</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Byron</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Fackelmayer</surname>
              <given-names>F.O.</given-names>
            </name>
            <name>
              <surname>Lawrence</surname>
              <given-names>J.B.</given-names>
            </name>
          </person-group>
          <article-title>Stable C0T-1 repeat RNA is abundant and is associated with euchromatic interphase chromosomes</article-title>
          <source>Cell</source>
          <volume>156</volume>
          <year>2014</year>
          <fpage>907</fpage>
          <lpage>919</lpage>
          <pub-id pub-id-type="pmid">24581492</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal" id="sref29">
          <person-group person-group-type="author">
            <name>
              <surname>Hancock</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>A new look at the nuclear matrix</article-title>
          <source>Chromosoma</source>
          <volume>109</volume>
          <year>2000</year>
          <fpage>219</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="pmid">10968250</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal" id="sref30">
          <person-group person-group-type="author">
            <name>
              <surname>Helbig</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Fackelmayer</surname>
              <given-names>F.O.</given-names>
            </name>
          </person-group>
          <article-title>Scaffold attachment factor A (SAF-A) is concentrated in inactive X chromosome territories through its RGG domain</article-title>
          <source>Chromosoma</source>
          <volume>112</volume>
          <year>2003</year>
          <fpage>173</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="pmid">14608463</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal" id="sref31">
          <person-group person-group-type="author">
            <name>
              <surname>Holmes</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Mayfield</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Sander</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bonner</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Chromosomal RNA: its properties</article-title>
          <source>Science</source>
          <volume>177</volume>
          <year>1972</year>
          <fpage>72</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">5041779</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal" id="sref32">
          <person-group person-group-type="author">
            <name>
              <surname>Ishida</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Prediction of disordered regions in proteins based on the meta approach</article-title>
          <source>Bioinformatics</source>
          <volume>24</volume>
          <year>2008</year>
          <fpage>1344</fpage>
          <lpage>1348</lpage>
          <pub-id pub-id-type="pmid">18426805</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal" id="sref33">
          <person-group person-group-type="author">
            <name>
              <surname>Jackson</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Pombo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Iborra</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>The balance sheet for transcription: an analysis of nuclear RNA metabolism in mammalian cells</article-title>
          <source>FASEB J.</source>
          <volume>14</volume>
          <year>2000</year>
          <fpage>242</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="pmid">10657981</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal" id="sref34">
          <person-group person-group-type="author">
            <name>
              <surname>Kelley</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Mezulis</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yates</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Wass</surname>
              <given-names>M.N.</given-names>
            </name>
            <name>
              <surname>Sternberg</surname>
              <given-names>M.J.E.</given-names>
            </name>
          </person-group>
          <article-title>The Phyre2 web portal for protein modeling, prediction and analysis</article-title>
          <source>Nat. Protoc.</source>
          <volume>10</volume>
          <year>2015</year>
          <fpage>845</fpage>
          <lpage>858</lpage>
          <pub-id pub-id-type="pmid">25950237</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal" id="sref35">
          <person-group person-group-type="author">
            <name>
              <surname>Kiledjian</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Dreyfuss</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box</article-title>
          <source>EMBO J.</source>
          <volume>11</volume>
          <year>1992</year>
          <fpage>2655</fpage>
          <lpage>2664</lpage>
          <pub-id pub-id-type="pmid">1628625</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal" id="sref36">
          <person-group person-group-type="author">
            <name>
              <surname>Klemm</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Austin</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>S.P.</given-names>
            </name>
          </person-group>
          <article-title>Coordinate binding of ATP and origin DNA regulates the ATPase activity of the origin recognition complex</article-title>
          <source>Cell</source>
          <volume>88</volume>
          <year>1997</year>
          <fpage>493</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="pmid">9038340</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal" id="sref37">
          <person-group person-group-type="author">
            <name>
              <surname>Langmead</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>S.L.</given-names>
            </name>
          </person-group>
          <article-title>Fast gapped-read alignment with Bowtie 2</article-title>
          <source>Nat. Methods</source>
          <volume>9</volume>
          <year>2012</year>
          <fpage>357</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="pmid">22388286</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal" id="sref38">
          <person-group person-group-type="author">
            <name>
              <surname>LlÃ¨res</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bailly</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Perrin</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Xirodimas</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Feil</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Quantitative FLIM-FRET microscopy to monitor nanoscale chromatin compaction inÂ vivo reveals structural roles of condensin complexes</article-title>
          <source>Cell Rep.</source>
          <volume>18</volume>
          <year>2017</year>
          <fpage>1791</fpage>
          <lpage>1803</lpage>
          <pub-id pub-id-type="pmid">28199849</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal" id="sref39">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Berezney</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Association of chromosome territories with the nuclear matrix. Disruption of human chromosome territories correlates with the release of a subset of nuclear matrix proteins</article-title>
          <source>J.Â Cell Biol.</source>
          <volume>146</volume>
          <year>1999</year>
          <fpage>531</fpage>
          <lpage>542</lpage>
          <pub-id pub-id-type="pmid">10444063</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal" id="sref40">
          <person-group person-group-type="author">
            <name>
              <surname>McHugh</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C.-K.</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Surka</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>McDonel</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Pandya-Jones</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Blanco</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Burghard</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Moradian</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3</article-title>
          <source>Nature</source>
          <volume>521</volume>
          <year>2015</year>
          <fpage>232</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="pmid">25915022</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal" id="sref41">
          <person-group person-group-type="author">
            <name>
              <surname>MelÃ©</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Rinn</surname>
              <given-names>J.L.</given-names>
            </name>
          </person-group>
          <article-title>âCatâs Cradlingâ the 3D genome by the act of lncRNA transcription</article-title>
          <source>Mol. Cell</source>
          <volume>62</volume>
          <year>2016</year>
          <fpage>657</fpage>
          <lpage>664</lpage>
          <pub-id pub-id-type="pmid">27259198</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal" id="sref42">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Voss</surname>
              <given-names>K.-O.</given-names>
            </name>
            <name>
              <surname>Tobias</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Jakob</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Durante</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Taucher-Scholz</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Clustered DNA damage induces pan-nuclear H2AX phosphorylation mediated by ATM and DNA-PK</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>41</volume>
          <year>2013</year>
          <fpage>6109</fpage>
          <lpage>6118</lpage>
          <pub-id pub-id-type="pmid">23620287</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal" id="sref43">
          <person-group person-group-type="author">
            <name>
              <surname>Naughton</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sproul</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hamilton</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Gilbert</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of active and inactive X chromosome architecture reveals the independent organization of 30Â nm and large-scale chromatin structures</article-title>
          <source>Mol. Cell</source>
          <volume>40</volume>
          <year>2010</year>
          <fpage>397</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="pmid">21070966</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal" id="sref44">
          <person-group person-group-type="author">
            <name>
              <surname>Naughton</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Avlonitis</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Corless</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Prendergast</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Mati</surname>
              <given-names>I.K.</given-names>
            </name>
            <name>
              <surname>Eijk</surname>
              <given-names>P.P.</given-names>
            </name>
            <name>
              <surname>Cockroft</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Bradley</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ylstra</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Gilbert</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Transcription forms and remodels supercoiling domains unfolding large-scale chromatin structures</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>20</volume>
          <year>2013</year>
          <fpage>387</fpage>
          <lpage>395</lpage>
          <pub-id pub-id-type="pmid">23416946</pub-id>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal" id="sref45">
          <person-group person-group-type="author">
            <name>
              <surname>Nozawa</surname>
              <given-names>R.-S.</given-names>
            </name>
            <name>
              <surname>Gilbert</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Interphase chromatin LINEd with RNA</article-title>
          <source>Cell</source>
          <volume>156</volume>
          <year>2014</year>
          <fpage>864</fpage>
          <lpage>865</lpage>
          <pub-id pub-id-type="pmid">24581484</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal" id="sref46">
          <person-group person-group-type="author">
            <name>
              <surname>Pederson</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Thinking about a nuclear matrix</article-title>
          <source>J.Â Mol. Biol.</source>
          <volume>277</volume>
          <year>1998</year>
          <fpage>147</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="pmid">9514762</pub-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal" id="sref47">
          <person-group person-group-type="author">
            <name>
              <surname>Phair</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Scaffidi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Elbi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>VecerovÃ¡</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dey</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ozato</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Hager</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bustin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Misteli</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Global nature of dynamic protein-chromatin interactions inÂ vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>24</volume>
          <year>2004</year>
          <fpage>6393</fpage>
          <lpage>6402</lpage>
          <pub-id pub-id-type="pmid">15226439</pub-id>
        </element-citation>
      </ref>
      <ref id="bib48">
        <element-citation publication-type="journal" id="sref48">
          <person-group person-group-type="author">
            <name>
              <surname>Ponting</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Schultz</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>SPRY domains in ryanodine receptors (Ca(2+)-release channels)</article-title>
          <source>Trends Biochem. Sci.</source>
          <volume>22</volume>
          <year>1997</year>
          <fpage>193</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="pmid">9204703</pub-id>
        </element-citation>
      </ref>
      <ref id="bib49">
        <element-citation publication-type="journal" id="sref49">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>S.S.P.</given-names>
            </name>
            <name>
              <surname>Huntley</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Durand</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Stamenova</surname>
              <given-names>E.K.</given-names>
            </name>
            <name>
              <surname>Bochkov</surname>
              <given-names>I.D.</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Sanborn</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Machol</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Omer</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Lander</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Aiden</surname>
              <given-names>E.L.</given-names>
            </name>
          </person-group>
          <article-title>A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping</article-title>
          <source>Cell</source>
          <volume>159</volume>
          <year>2014</year>
          <fpage>1665</fpage>
          <lpage>1680</lpage>
          <pub-id pub-id-type="pmid">25497547</pub-id>
        </element-citation>
      </ref>
      <ref id="bib50">
        <element-citation publication-type="journal" id="sref50">
          <person-group person-group-type="author">
            <name>
              <surname>Romig</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Fackelmayer</surname>
              <given-names>F.O.</given-names>
            </name>
            <name>
              <surname>Renz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ramsperger</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Richter</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of SAF-A, a novel nuclear DNA binding protein from HeLa cells with high affinity for nuclear matrix/scaffold attachment DNA elements</article-title>
          <source>EMBO J.</source>
          <volume>11</volume>
          <year>1992</year>
          <fpage>3431</fpage>
          <lpage>3440</lpage>
          <pub-id pub-id-type="pmid">1324173</pub-id>
        </element-citation>
      </ref>
      <ref id="bib51">
        <element-citation publication-type="journal" id="sref51">
          <person-group person-group-type="author">
            <name>
              <surname>Roshon</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Ruley</surname>
              <given-names>H.E.</given-names>
            </name>
          </person-group>
          <article-title>Hypomorphic mutation in hnRNP U results in post-implantation lethality</article-title>
          <source>Transgenic Res.</source>
          <volume>14</volume>
          <year>2005</year>
          <fpage>179</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="pmid">16022389</pub-id>
        </element-citation>
      </ref>
      <ref id="bib52">
        <element-citation publication-type="journal" id="sref52">
          <person-group person-group-type="author">
            <name>
              <surname>Samejima</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Samejima</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Vagnarelli</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Vargiu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>de Lima Alves</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Kerr</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Hudson</surname>
              <given-names>D.F.</given-names>
            </name>
          </person-group>
          <article-title>Mitotic chromosomes are compacted laterally by KIF4 and condensin and axially by topoisomerase IIÎ±</article-title>
          <source>J.Â Cell Biol.</source>
          <volume>199</volume>
          <year>2012</year>
          <fpage>755</fpage>
          <lpage>770</lpage>
          <pub-id pub-id-type="pmid">23166350</pub-id>
        </element-citation>
      </ref>
      <ref id="bib53">
        <element-citation publication-type="journal" id="sref53">
          <person-group person-group-type="author">
            <name>
              <surname>Schultz</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Milpetz</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ponting</surname>
              <given-names>C.P.</given-names>
            </name>
          </person-group>
          <article-title>SMART, a simple modular architecture research tool: identification of signaling domains</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>95</volume>
          <year>1998</year>
          <fpage>5857</fpage>
          <lpage>5864</lpage>
          <pub-id pub-id-type="pmid">9600884</pub-id>
        </element-citation>
      </ref>
      <ref id="bib54">
        <element-citation publication-type="journal" id="sref54">
          <person-group person-group-type="author">
            <name>
              <surname>Sekimizu</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Bramhill</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kornberg</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>ATP activates dnaA protein in initiating replication of plasmids bearing the origin of the E.Â coli chromosome</article-title>
          <source>Cell</source>
          <volume>50</volume>
          <year>1987</year>
          <fpage>259</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="pmid">3036372</pub-id>
        </element-citation>
      </ref>
      <ref id="bib55">
        <element-citation publication-type="journal" id="sref55">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>M.-Y.</given-names>
            </name>
            <name>
              <surname>Sali</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Statistical potential for assessment and prediction of protein structures</article-title>
          <source>Protein Sci.</source>
          <volume>15</volume>
          <year>2006</year>
          <fpage>2507</fpage>
          <lpage>2524</lpage>
          <pub-id pub-id-type="pmid">17075131</pub-id>
        </element-citation>
      </ref>
      <ref id="bib56">
        <element-citation publication-type="journal" id="sref56">
          <person-group person-group-type="author">
            <name>
              <surname>Stivala</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wybrow</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wirth</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Whisstock</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Stuckey</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <article-title>Automatic generation of protein structure cartoons with Pro-origami</article-title>
          <source>Bioinformatics</source>
          <volume>27</volume>
          <year>2011</year>
          <fpage>3315</fpage>
          <lpage>3316</lpage>
          <pub-id pub-id-type="pmid">21994221</pub-id>
        </element-citation>
      </ref>
      <ref id="bib57">
        <element-citation publication-type="journal" id="sref57">
          <person-group person-group-type="author">
            <name>
              <surname>Thandapani</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>OâConnor</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Richard</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Defining the RGG/RG motif</article-title>
          <source>Mol. Cell</source>
          <volume>50</volume>
          <year>2013</year>
          <fpage>613</fpage>
          <lpage>623</lpage>
          <pub-id pub-id-type="pmid">23746349</pub-id>
        </element-citation>
      </ref>
      <ref id="bib58">
        <element-citation publication-type="journal" id="sref58">
          <person-group person-group-type="author">
            <name>
              <surname>Trapnell</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Goff</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Pertea</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kelley</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Rinn</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Pachter</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks</article-title>
          <source>Nat. Protoc.</source>
          <volume>7</volume>
          <year>2012</year>
          <fpage>562</fpage>
          <lpage>578</lpage>
          <pub-id pub-id-type="pmid">22383036</pub-id>
        </element-citation>
      </ref>
      <ref id="bib59">
        <element-citation publication-type="journal" id="sref59">
          <person-group person-group-type="author">
            <name>
              <surname>Xiao</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Shao</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>X.-D.</given-names>
            </name>
          </person-group>
          <article-title>Nuclear matrix factor hnRNP U/SAF-A exerts a global control of alternative splicing by regulating U2 snRNP maturation</article-title>
          <source>Mol. Cell</source>
          <volume>45</volume>
          <year>2012</year>
          <fpage>656</fpage>
          <lpage>668</lpage>
          <pub-id pub-id-type="pmid">22325991</pub-id>
        </element-citation>
      </ref>
      <ref id="bib60">
        <element-citation publication-type="journal" id="sref60">
          <person-group person-group-type="author">
            <name>
              <surname>Ye</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Beetz</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>OâKeeffe</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tapia</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Macpherson</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W.V.</given-names>
            </name>
            <name>
              <surname>Bassel-Duby</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>E.N.</given-names>
            </name>
            <name>
              <surname>Maniatis</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>hnRNP U protein is required for normal pre-mRNA splicing and postnatal heart development and function</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>112</volume>
          <year>2015</year>
          <fpage>E3020</fpage>
          <lpage>E3029</lpage>
          <pub-id pub-id-type="pmid">26039991</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app2" sec-type="supplementary-material">
      <title>Supplemental Information</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Table S1</title>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack id="ack0010">
      <title>Acknowledgments</title>
      <p>We thank Shelagh Boyle for help with microscopy and image analysis, David LlÃ¨res for advice on FLIM-FRET, Wendy Bickmore, Javier Caceres, and Nick Hastie for helpful discussions and comments on the manuscript. This work was funded by a <funding-source id="gs1">UK Medical Research Council</funding-source> senior non-clinical fellowship (MR/J00913X/1) to N.G., and R.-S.N. was supported by a Postdoctoral Fellowship for Research Abroad from the <funding-source id="gs3">Japan Society for the Promotion of Science</funding-source> (JSPS).</p>
    </ack>
    <fn-group>
      <fn id="app1" fn-type="supplementary-material">
        <p>Supplemental Information includes seven figures and one table and can be found with this article online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.cell.2017.05.029" id="intref0175">http://dx.doi.org/10.1016/j.cell.2017.05.029</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>